rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCCCAACGTCGATAGGTACCTACGAGCAGTACTTCGGGCCG	CASSVPTSIGTYEQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	2	5	4	2	12	2	23	37	52	49	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVPTSIGTYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCACACATCGGGAACACCATATATTTTGGAGAG	CASSPHIGNTIYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	8	4	7	8	0	23	35	-1	43	47			01,02			01,02							Vb 1	CASSPHIGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAATGAAGAAGGGACAGGGGGCGTGTGGCTACACCTTCGGTTCG		Out	VDJ	1	15	4.018861858321723E-4		53	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	0	7	9	3	23	39	60	48	63			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCCAGGGGGCCGTAAACACTGAAGCTTTCTTTGGACAA	CASSSQGAVNTEAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	2	3	4	23	35	46	38	50			01,02										Vb 1	CASSSQGAVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTAGGTCGGTCCAATCAGCCCCAGCATTTTGGTGAT	CASSVGRSNQPQHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	3	2	2	23	39	44	41	46			01,02			01,02							Vb 1	CASSVGRSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACTCCAAGAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTPRSSGANVLTF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	3	10	0	0	8	23	-1	38	35	46			01,02			01,02							Vb 1	CASSTPRSSGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD02-01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAATCCGGGACCGTTTAATTCACCCCTCCACTTTGGGAAC	CASSVNPGPFNSPLHF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-06	01	1	0	7	6	5	4	23	38	48	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVNPGPFNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSPGTNTEAFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	0	7	1	3	0	23	35	-1	38	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPGTNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCTGGGGACACCCAAAAGAGACCCAGTACTTCGGGCCA	CASSVWGHPKETQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	3	3	5	23	37	46	40	51			01,02										Vb 1	CASSVWGHPKETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCCAATGGGGCGGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSAPMGRGDYNEQFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	1	3	10	1	23	36	54	46	55			01,02										Vb 1	CASSAPMGRGDYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGTGAGGGGACCGTTTGAAGCTTTCTTTGGACAA	CASSVDVRGPFEAFF	In	VDJ	2	49	0.001312828207051763	0.0016414860473685973	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	0	7	7	7	4	23	39	51	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDVRGPFEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAATGGAAGTACGAGCAGTACTTCGGGCCG	CASSEWKYEQYF	In	VDJ	2	59	0.0015807523309398779	0.001976483199892801	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	5	1	8	4	5	2	23	34	42	39	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEWKYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCCCAGGAACCTACAATGAGCAGTTCTTCGGGCCA	CASSRPGTYNEQFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	4	2	3	2	29	42	49	45	51													Vb 16	CASSRPGTYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTACTCCCCCCGACAGGGCGCTACGAGCAGTACTTCGGGCCG	CASSLLPPTGRYEQYF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	3	10	2	29	42	59	52	61													Vb 16	CASSLLPPTGRYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTGACAAAAGAGACCCAGTACTTCGGGCCA	CASSQDLTKETQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	6	3	3	1	29	46	53	49	54													Vb 16	CASSQDLTKETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGTCACTAGCGGGGGGTACCTACGAGCAGTACTTCGGGCCG	CASSQSLAGGTYEQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	2	3	2	29	43	58	46	60													Vb 16	CASSQSLAGGTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCCCCTACCAGGGGGGGGGATAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	15	4.018861858321723E-4		58	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	2	4	1	1	8	6	16	31	46	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCAGGGAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	5.894330725538528E-4		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	9	0	4	2	0	29	45	-1	47	54													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGGGGGGGCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	6.162254849426642E-4		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	6	1	2	29	46	55	47	57													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAAGGACAAGGATCTACGAGCAGTACTTCGGGCCG	CASSQGRTRIYEQYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	6	3	3	5	29	45	53	48	58													Vb 16	CASSQGRTRIYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAAGGGACAGACTTTACGAGCAGTACTTCGGGCCG	CASSQGRDRLYEQYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	4	3	4	29	45	55	48	59													Vb 16	CASSQGRDRLYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAAACCTGGCATTACAGTGAACACTGAAGCTTTCTTTGGACAA	CASKPGITVNTEAFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	5	0	11	0	29	39	-1	50	54													Vb 16	CASKPGITVNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGACAGGGAATTCACCCCTCCACTTTGGGAAC	CASSRTGNSPLHF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	3	7	0	0	29	-1	-1	42	50													Vb 16	CASSRTGNSPLHF+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCAGGGATGAGGGCTGGAAACACCATATATTTTGGAGAG	CASSQDPGMRAGNTIYF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	51	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	0	4	3	2	2	7	29	46	53	48	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDPGMRAGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTACAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSQLQGGTEAFF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	4	2	1	29	44	54	46	55													Vb 16	CASSQLQGGTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGAGAACAGGGGAGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	9.91319258386025E-4		34	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	8	3	1	29	40	50	43	51													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGACAGGGTTCGATCGCTGAAGCTTTCTTTGGACAA	CASSQGQGSIAEAFF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	6	0	8	29	-1	52	45	60													Vb 16	CASSQGQGSIAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGGGAAAGGGGGTATGGCTACACCTTCGGTTCG	CASSGERGYGYTF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	1	5	6	0	29	41	-1	47	53													Vb 16	CASSGERGYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTTTACCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	49	0.001312828207051763		43	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	2	3	7	0	4	0	29	44	-1	48	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCGGGACAAACACTTGGCTACATCTTCGGTTCG	CASSQPGQTLGYIF	In	VDJ	2	51	0.0013664130318293858	0.0017084854778734381	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	16	2	15	29	44	52	46	67													Vb 16	CASSQPGQTLGYIF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTACCTCACAGGGGATGCACGAGCAGTACTTCGGGCCG	CASSTSQGMHEQYF	In	VDJ	2	57	0.0015271675061622548	0.0019094837693879603	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	5	6	4	29	40	53	46	57													Vb 16	CASSTSQGMHEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGATATTCTAGGGGGCAGCGGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	66	0.0017682992176615584		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	5	0	9	7	5	29	40	54	47	59													Vb 16	X+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGACAGAGGGACCTGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	68	0.0018218840424391813		43	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	6	0	7	3	5	6	29	40	50	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGTGGGGGACCCAGTACTTCGGGCCA	CASSQEWGTQYF	In	VDJ	2	74	0.00198263851677205	0.0024789789286791064	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	6	2	7	2	0	29	46	-1	48	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQEWGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCTTCGATCAGCCCCAGCATTTTGGTGAT	CASSLFDQPQHF	In	VDJ	2	74	0.00198263851677205	0.0024789789286791064	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	4	10	5	1	3	29	42	45	43	48						01,02							Vb 16	CASSLFDQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCCTAGACAGGGGCGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASTLDRGEGNQPQHF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	2	2	2	8	5	24	31	47	39	52														CASTLDRGEGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTAACGAGGGTCCCGGGTCCCTCTATGGCTACACCTTCGGTTCG	CASSPNEGPGSLYGYTF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	0	4	6	12	24	36	47	42	59														CASSPNEGPGSLYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAAATAGGGTTAAACACTGAAGCTTTCTTTGGACAA	CASSVEIGLNTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	5	3	2	8	3	24	36	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEIGLNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGTGGACAGGGGTCGATGAAAAACTGTTTTTTGGCAGT	CASKWTGVDEKLFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	1	2	6	6	3	24	31	46	37	49														CASKWTGVDEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGGTAGGGGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	2.947165362769264E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	1	4	0	24	35	-1	39	46														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGGTGTCAACACGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	3.2150894866573784E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	2	7	4	24	0	24	36	-1	60	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCCTGGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSVSWGGETQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	5	8	0	24	36	-1	44	51														CASSVSWGGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGAGGACAGAGAAATCAGCCCCAGCATTTTGGTGAT	CASSLGGQRNQPQHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	7	3	24	35	48	42	51														CASSLGGQRNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCCTGACAGGGGGGAGGCAGCCCCAGCATTTTGGTGAT	CASTLTGGRQPQHF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	2	1	7	7	4	24	31	47	38	51														CASTLTGGRQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTCGGGGGTTCTACTGAAGCTTTCTTTGGACAA	CASSFGGSTEAFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	5	2	4	24	36	44	38	48														CASSFGGSTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGTCAGCAGCAAAGAGGCAGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	4.822634229986068E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	3	3	0	24	40	-1	43	48														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTGCCACCGGGGGAGATACGCAGTATTTTGGCCCA	CASSPATGGDTQYF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	2	5	8	0	24	36	-1	44	50														CASSPATGGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACTGGATGGCAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	6.162254849426642E-4		41	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	2	1	8	5	2	6	24	39	44	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGTAAAGGTGGGAAGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	30	8.037723716643446E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	10	0	8	4	12	16	24	31	47	43	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACCTTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	31	8.305647840531562E-4		38	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	4	10	3	1	1	24	39	42	40	43						01,02								X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATTATAGGCAGATCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	8.305647840531562E-4		44	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	4	4	5	2	7	3	24	37	47	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAAGCGAACAGGTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	9.91319258386025E-4		43	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	4	3	5	2	24	39	49	44	51														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAGGGCAGGGGGCCGATACGCAGTATTTTGGCCCA	CASSPGQGADTQYF	In	VDJ	3	84	0.002250562640660165	0.00281397608120331	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	6	6	1	24	36	50	42	51														CASSPGQGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAGGGTTGTTGAACACTGAAGCTTTCTTTGGACAA	CASSPGLLNTEAFF	In	VDJ	3	97	0.0025988640017147145	0.0032494723794847745	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	1	4	24	36	42	37	46														CASSPGLLNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAGTTTAAGGTGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	13	3.4830136105454935E-4		53	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-06	01	2	5	4	0	6	4	18	33	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-06	TCRBV07-06*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGGCGGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGGAYNEQFF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	0	2	2	0	18	32	-1	34	43														CASSLGGGAYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTACGGGCCGGGACAGGGAGGGATGGCTACACCTTCGGTTCG	CASSLRAGTGRDGYTF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	6	6	4	18	33	48	39	52														CASSLRAGTGRDGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATCGGGAGACAGGGCCGGCTACACCTTCGGTTCG	CASSLSGDRAGYTF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	8	6	2	18	33	46	39	48														CASSLSGDRAGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGAAGCACGGGACAGGGTAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	6.698103097202872E-4		44	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	3	2	3	18	30	41	32	44														X+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGAGGACAGGGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEDRGATNEKLFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	2	0	2	2	18	30	41	32	43														CASSEDRGATNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCTCCCCCGGACAGGGAAATGAAAAACTGTTTTTTGGCAGT	CASTSPGQGNEKLFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	1	3	5	8	1	18	28	44	36	45														CASTSPGQGNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCACCGACGGATCCGTGGAATACGCAGTATTTTGGCCCA	CASSSPTDPWNTQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	3	1	8	7	7	8	19	32	42	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPTDPWNTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTACAGGGGGTGACCTACGAGCAGTACTTCGGGCCG	CASSLQGVTYEQYF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	0	3	19	-1	41	34	44														CASSLQGVTYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTCGGGACGACTCTCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	5.090558353874183E-4		47	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-01	01	2	0	7	3	2	9	19	33	40	35	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCATAATAGACCCCCTCACAGCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	5.626406601650412E-4		47	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-07	01	4	3	5	5	15	2	19	31	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGCCGGTATAGGGGATTCACCCCTCCACTTTGGGAAC	CASSAGIGDSPLHF	In	VDJ	3	93	0.0024916943521594683	0.003115473518475093	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	5	2	8	8	0	19	31	-1	39	44														CASSAGIGDSPLHF+TCRBV07-05+TCRBJ01-06	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTGTCAGCCAACACTGAAGCTTTCTTTGGACAA	CASSEVSANTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	4	5	2	3	2	23	39	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEVSANTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAAGGGTGGGAGACCCAGTACTTCGGGCCA	CASSEEGWETQYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	39	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-05	01	1	5	3	5	1	3	23	39	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEGWETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTAATAGCGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSEVIAGNTDTQYF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	3	2	3	2	23	39	50	42	52														CASSEVIAGNTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTTCCCGGACAGGGACCGAGACCCAGTACTTCGGGCCA	CASSEVSRTGTETQYF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	3	5	6	3	23	39	53	45	56														CASSEVSRTGTETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGCGGTTCAGGGCCCCAGCATTTTGGTGAT		Out	VDJ	2	69	0.0018486764548279928		40	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	6	5	9	0	6	23	-1	44	39	50						01,02								X+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCGGGACTACCTCGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	6.430178973314757E-4		44	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	9	4	2	7	22	34	43	36	50						01,02								X+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGCAAGCCACGTTTGGTGCTCCTCAGTGACTCTGGCTTCTTCTCTGTGCCTGGAGCCTCCAGGGCTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	2.411317114993034E-4		35	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	19	4	3	6	19	2	46	41	65	60	67													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGCAAGCCACGTTTGGTGCTTCTCAGTGACTCTGGCTCTATCTCTGTGCCTGGAGCCTCCAGGGCTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.679241238881149E-4		35	TCRBV30	TCRBV30-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	22	4	3	6	22	2	46	38	65	60	67			01,02										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAGACAGACACCTCAAGTTGGAAAAACTGTTTTTTGGCAGT	CA*DRHLKLEKLFF	Stop	VDJ	1	10	2.679241238881149E-4		42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	5	8	1	13	26	34	40	35	53													Vb 20	CA*DRHLKLEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGACCGACAGGGGGTCACTGAAGCTTTCTTTGGACAA	CAWSDRQGVTEAFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	5	1	26	37	51	42	52													Vb 20	CAWSDRQGVTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCATCAACAGGGTATAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	2.679241238881149E-4		41	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	8	6	3	26	38	50	44	53													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCCCCGGAGGGTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	11	2.947165362769264E-4		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	10	0	1	4	0	26	35	-1	39	45			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCCCTCGGAGAGTAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	2.947165362769264E-4		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	2	4	5	5	26	35	44	40	49													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGGGGACGGCTACGAGCAGTACTTCGGGCCG	CAWSAGDGYEQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	2	3	0	4	26	-1	45	39	49													Vb 20	CAWSAGDGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTGGGCGGGTATGGCTACACCTTCGGTTCG	CAWSLGGYGYTF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	4	5	5	0	26	37	-1	42	47						01,02							Vb 20	CAWSLGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAAGTTTAGGGGGGGGCGATTCACCCCTCCACTTTGGGAAC	CAWSVLSLGGGDSPLHF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	51	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	9	0	8	10	3	26	40	57	50	60			unresolved										Vb 20	CAWSVLSLGGGDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCGTAGGACGTGGCGGTAATGAAAAACTGTTTTTTGGCAGT	CAVGRGGNEKLFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	8	1	7	4	3	7	26	32	39	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAVGRGGNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCACTGGGCTACCAGAACAATGAGCAGTTCTTCGGGCCA	CAWSALGYQNNEQFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	5	6	7	26	37	47	43	54			unresolved										Vb 20	CAWSALGYQNNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGAGCTTTGACTATGGCTACACCTTCGGTTCG	CAWSRSFDYGYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	2	3	1	5	26	38	43	39	48			unresolved										Vb 20	CAWSRSFDYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGGGACAGGGGGGCGTTATAATTCACCCCTCCACTTTGGGAAC	CAWSPGTGGRYNSPLHF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	1	4	3	4	26	38	52	41	56			unresolved										Vb 20	CAWSPGTGGRYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTTCTAGGAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSPSRRAGANVLTF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	10	0	2	7	0	26	38	-1	45	51													Vb 20	CAWSPSRRAGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAATCCCCCCGGCAGGCCGTCCTGAAAAACTGTTTTTTGGCAGT	CAWSVIPPAGRPEKLFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	4	7	11	6	26	40	55	51	61													Vb 20	CAWSVIPPAGRPEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGGGGGAACTAACTACGAGCAGTACTTCGGGCCG	CAWSWGGTNYEQYF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	9	0	3	1	6	26	38	46	39	52			unresolved										Vb 20	CAWSWGGTNYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCTGCGGGACAGGATAATTCACCCCTCCACTTTGGGAAC	CAWSAGQDNSPLHF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	4	5	5	0	26	35	-1	40	48			unresolved										Vb 20	CAWSAGQDNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAGAAACAGATACGCAGTATTTTGGCCCA	CAWSVLETDTQYF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	8	3	0	2	26	-1	45	40	47						01,02							Vb 20	CAWSVLETDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCCATTGGGGACTGAAGCTTTCTTTGGACAA	CAWRPLGTEAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	3	6	2	5	6	0	26	37	-1	43	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRPLGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTAGCGGGGGGGCCGGGCTTAATGAGCAGTTCTTCGGGCCA	CAWSVSGGAGLNEQFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	7	0	8	26	-1	51	40	59													Vb 20	CAWSVSGGAGLNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACGTGGGTGCCAGGAACTAATGAAAAACTGTTTTTTGGCAGT	CAWGTWVPGTNEKLFF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	48	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	5	0	7	1	0	12	26	-1	40	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGTWVPGTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCGGGACAGGGGATATTCTACGAGCAGTACTTCGGGCCG	CAWTPGQGIFYEQYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	4	5	26	36	50	40	55													Vb 20	CAWTPGQGIFYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCCCCCCGGGGGGCCAGAATGAAAAACTGTTTTTTGGCAGT	CAWSVRPPGGQNEKLFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	51	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	1	5	8	4	26	40	55	48	59													Vb 20	CAWSVRPPGGQNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAAGGTTCACCCCTCCACTTTGGGAAC	CAWSVQGSPLHF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	0	3	6	9	0	3	26	-1	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVQGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTCGGGACAGTAATGAAAAACTGTTTTTTGGCAGT	CAWSVRDSNEKLFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	5	4	2	0	26	40	-1	42	49													Vb 20	CAWSVRDSNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCGGACAGGGGGCTGGGGGCACTGAAGCTTTCTTTGGACAA	CASGQGAGGTEAFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	0	4	2	6	26	33	46	35	52													Vb 20	CASGQGAGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCGGGACAGGGGGCGGAAGGCTACACCTTCGGTTCG	CAWSVSGQGAEGYTF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	0	8	3	4	26	40	55	43	59			unresolved										Vb 20	CAWSVSGQGAEGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTAGAGTCCTCCGACAGGGGGGTACGAGCAGTACTTCGGGCCG	CA*SPPTGGYEQYF	Stop	VDJ	1	30	8.037723716643446E-4		42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	1	4	5	1	26	38	52	43	53													Vb 20	CA*SPPTGGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTCCGACAGGGGGGTACGAGCAGTACTTCGGGCCG	CAWSPPTGGYEQYF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	1	4	5	1	26	38	52	43	53													Vb 20	CAWSPPTGGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGACAGCTCGTTTCGAAAAACTGTTTTTTGGCAGT	CAWATARFEKLFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	8	2	8	26	35	42	37	50													Vb 20	CAWATARFEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAGACTCCTCACCCAAGAGACCCAGTACTTCGGGCCA	CAWTRLLTQETQYF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	10	1	3	6	26	36	43	39	49						01,02							Vb 20	CAWTRLLTQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGAGTACGAGCAGTACTTCGGGCCG	CAWSVREYEQYF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	2	4	1	0	26	40	-1	41	47													Vb 20	CAWSVREYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCATCGGACGTACCCTTAGGAAACACCATATATTTTGGAGAG	CAWSASDVPLGNTIYF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	48	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	1	1	7	4	4	9	26	39	47	43	56			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSASDVPLGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCAGGGGATGACACTGAAGCTTTCTTTGGACAA	CAWSAGDDTEAFF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	2	3	26	37	45	39	48			unresolved										Vb 20	CAWSAGDDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	44	0.0011788661451077056		34	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	5	4	0	1	26	-1	43	40	44						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACAGGGGGCGCGGGAATTCACCCCTCCACTTTGGGAAC	CAWSDRGRGNSPLHF	In	VDJ	2	54	0.0014467902689958203	0.0018089846236306992	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	3	0	7	0	5	26	-1	48	39	53			unresolved										Vb 20	CAWSDRGRGNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCACTTGGGCAGTACGATTCACCCCTCCAYTTTGGGAAC	CAWSPLGQYDSPLHF	In	VDJ	2	65	0.0017415068052727468	0.002177481491407323	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	8	0	22	6	20	26	38	48	44	68													Vb 20	CAWSPLGQYDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTTTTTAAACAGGGCCTTAGAGACCCAGTACTTCGGGCCA	CAWFLNRALETQYF	In	VDJ	2	70	0.0018754688672168042	0.0023449800676694247	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	4	7	4	26	35	48	42	52			unresolved										Vb 20	CAWFLNRALETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTCCAGGGCTCTGAAGCTTTCTTTGGACAA	CAWSLQGSEAFF	In	VDJ	66	2117	0.05671953702711392	0.07091889718937389	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	6	4	2	26	37	46	41	48			unresolved										Vb 20	CAWSLQGSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTTCAACAGGAACAGATACGCAGTATTTTGGCCCA	CASSQVSTGTDTQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	4	3	5	1	23	39	49	44	50														CASSQVSTGTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGTGGTACAGGAGCACTGAAGCTTTCTTTGGACAA	CASSQEWYRSTEAFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	4	5	2	23	40	50	45	52														CASSQEWYRSTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCCCCAGGGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQDPQGSSYNSPLHF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	3	0	4	3	23	40	49	44	52														CASSQDPQGSSYNSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACAGGGGCTACGAGCAGTACTTCGGGCCG	CASSQDRGYEQYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	3	0	0	23	-1	-1	40	46														CASSQDRGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGAGGGGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSQEEGGSTDTQYF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	48	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	0	5	1	0	2	2	23	40	48	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEEGGSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAATTGGGACAGGATCTAACTATGGCTACACCTTCGGTTCG	CASSLIGTGSNYGYTF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	0	4	2	19	33	45	37	47													Vb 5.1	CASSLIGTGSNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATGGGACAGGGGATTACGAGCAGTACTTCGGGCCG	CASSLDGTGDYEQYF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	4	2	2	19	35	47	37	49													Vb 5.1	CASSLDGTGDYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACGACAGCTAACACTGAAGCTTTCTTTGGACAA	CASSLGTTANTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	2	4	2	19	35	44	39	46													Vb 5.1	CASSLGTTANTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCAGGGAGGGACACTGAAGCTTTCTTTGGACAA	CASSLSGRDTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	0	3	3	0	19	34	-1	37	44													Vb 5.1	CASSLSGRDTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGACAGGGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	10	2.679241238881149E-4		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	3	6	3	0	19	31	-1	34	43													Vb 5.1	X+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGCTGGCGAGACAGGGGGGGAGACCCAGTACTTCGGGCCA	CASSAGETGGETQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	1	5	8	1	19	31	48	39	49													Vb 5.1	CASSAGETGGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTTAGACAGGGGGTAGTCAATGAGCAGTTCTTCGGGCCA	CASSLRQGVVNEQFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	1	6	4	4	19	31	44	35	48													Vb 5.1	CASSLRQGVVNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCCGGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	2.947165362769264E-4		46	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	3	2	1	19	33	44	35	45													Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTATCTGGGACGGTCGACCTACGAGCAGTACTTCGGGCCG	CASSLYLGRSTYEQYF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	2	5	6	19	34	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLYLGRSTYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACCGTGGAGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSWTVERTGELFF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	3	1	7	5	0	10	19	-1	36	32	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSWTVERTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGGACAGGGGAAAATGAAAAACTGTTTTTTGGCAGT	CASSLRTGENEKLFF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	2	5	1	2	19	34	44	35	46													Vb 5.1	CASSLRTGENEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACAGTACAGGAACTATGGCTACACCTTCGGTTCG	CASSLEQYRNYGYTF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	2	6	0	19	35	-1	41	46													Vb 5.1	CASSLEQYRNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCAGGTCTCCTCTGGAAACACCATATATTTTGGAGAG	CASSLAQVSSGNTIYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	4	0	2	4	19	35	41	37	45													Vb 5.1	CASSLAQVSSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGTTAGGGGCAAGCACAGATACGCAGTATTTTGGCCCA	CASSLVLGASTDTQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	0	4	2	19	35	44	39	46													Vb 5.1	CASSLVLGASTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGCCGGGACGGACTACCACAGATACGCAGTATTTTGGCCCA	CASSQPGRTTTDTQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	9	2	10	1	19	31	47	41	48						01,02							Vb 5.1	CASSQPGRTTTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGGACAGGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSLRTGIYNEQFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	3	3	1	2	19	34	43	35	45													Vb 5.1	CASSLRTGIYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCCAGCAGCCACGGACAGGCGCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	5.090558353874183E-4		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	13	1	4	3	10	3	19	22	39	32	42													Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAGTGGGACAGCACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	5.090558353874183E-4		41	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	3	3	2	19	29	39	32	41													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGGACAGGGGATTACGAGCAGTACTTCGGGCCG	CASSSGTGDYEQYF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	4	2	2	19	32	44	34	46													Vb 5.1	CASSSGTGDYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATTGGGGGTCAAGGCGAAGCTTTCTTTGGACAA	CASSLIGGQGEAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	1	6	1	8	3	7	19	34	42	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLIGGQGEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACCAGGGTGGGGTGAAAAACTGTTTTTTGGCAGT	CASSLEPGWGEKLFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	7	3	5	19	35	43	38	48													Vb 5.1	CASSLEPGWGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGACAGGGCCGGGGACTGAAGCTTTCTTTGGACAA	CASSPTGPGTEAFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	5	2	6	19	31	40	33	46													Vb 5.1	CASSPTGPGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGTTTTCGGTCGCGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	60	0.0016075447433286892		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	5	3	11	0	19	33	-1	44	48						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASSLTTGDYEQYF	In	VDJ	2	69	0.0018486764548279928	0.0023114803524170043	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	3	2	1	19	34	44	36	45													Vb 5.1	CASSLTTGDYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAACCGACGGACAGGGGTTTAGGACCCAGTACTTCGGGCCA	CASSSTDGQGFRTQYF	In	VDJ	3	92	0.002464901939770657	0.0030819738032226724	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	2	7	8	5	19	32	49	40	54													Vb 5.1	CASSSTDGQGFRTQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCCCTGGGCCAGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSPGPVSYNEQFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	0	5	4	25	41	50	46	54													Vb 3	CASSLSPGPVSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAATGTCGTACGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPMSYGGNTEAFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	1	11	0	25	37	-1	48	54													Vb 3	CASSPMSYGGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCACGATACCTCTACAATGAGCAGTTCTTCGGGCCA	CASSSPRYLYNEQFF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	4	2	8	3	6	5	25	38	46	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSPRYLYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSFPSYNSPLHF	In	VJ	1	18	4.822634229986068E-4	6.029948745435664E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	3	0	0	0	0	3	25	-1	39	-1	42													Vb 3	CASSFPSYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGAGGGGAACTATGGCTACACCTTCGGTTCG	CASSWEGNYGYTF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	2	0	1	25	-1	45	38	46													Vb 3	CASSWEGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAAGGACAGGAGCGGGGGAGCAGTACTTCGGGCCG	CASSLRTGAGEQYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	1	4	7	4	7	25	37	48	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLRTGAGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCGTAGGGCTGAAGCTTTCTTTGGACAA	CASSSRRAEAFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	5	3	6	5	0	25	38	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSRRAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCGACAACTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLFDNSYNSPLHF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	6	0	2	1	25	41	47	43	48													Vb 3	CASSLFDNSYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCGGACAGGGCGAGGCGATGAAAAACTGTTTTTTGGCAGT	CASSPRTGRGDEKLFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	6	4	7	25	37	49	41	56													Vb 3	CASSPRTGRGDEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGTCGCCGGGGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASRVAGGVNTEAFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	0	6	2	25	36	48	42	50													Vb 3	CASRVAGGVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGAACACTGAAGCTTTCTTTGGACAA	CASSLENTEAFF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	2	8	1	0	0	25	-1	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCAGCTCTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	48	0.0012860357946629514		55	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	2	6	5	9	7	25	40	53	49	60													Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGCGCCGGTGGACACTGAAGCTTTCTTTGGACAA	CASRAPVDTEAFF	In	VDJ	3	84	0.002250562640660165	0.00281397608120331	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	9	0	3	0	8	25	-1	39	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRAPVDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTCGGGACTGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	9	2.411317114993034E-4		41	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	0	1	1	18	31	38	32	39						01,02								X+TCRBV12-02+TCRBJ02-05	TCRBV12-02*01	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTAGACCCGGGACAGCGAGCTAATTGGAGAAAAACTGTTTTTTGGCAGT	CASR*TRDSELIGEKLFF	Stop	VDJ	1	16	4.286785982209838E-4		54	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	8	6	13	18	31	44	37	57														CASR*TRDSELIGEKLFF+TCRBV12-02+TCRBJ01-04	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGTGGTCCCGAGCGGGGGGGTGGTAGTTCACCCCTCCACTTTGGGAAC	CASGPERGGGSSPLHF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	8	6	0	9	7	6	18	27	44	34	50														CASGPERGGGSSPLHF+TCRBV12-02+TCRBJ01-06	TCRBV12-02*01	TCRBD02-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTCAGCCGGGGGGATTGGGAATTCACCCCTCCACTTTGGGAAC	CASSSAGGIGNSPLHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	48	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	8	1	7	4	6	23	36	47	40	53													Vb 14	CASSSAGGIGNSPLHF+TCRBV27-01+TCRBJ01-06	TCRBV27-01*01	TCRBD02-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGACCGGGAACCGGTGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	52	0.0013932054442181974		46	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	8	3	2	2	8	23	34	41	36	49													Vb 14	X+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD02-01*02	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGGTCAAAACAGGAGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASRSKQETSNQPQHF	In	VDJ	2	61	0.0016343371557175008	0.0020434826303976418	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	4	0	6	4	23	34	45	40	49													Vb 14	CASRSKQETSNQPQHF+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCGGTTACAGGGGCACCAAGAGATCACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	9	2.411317114993034E-4		53	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	7	8	13	25	35	50	43	63													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCAGACAGGGGTGGAAACTATGGCTACACCTTCGGTTCG	CSADRGGNYGYTF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	2	2	2	4	25	32	42	34	46													Vb 4	CSADRGGNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGAGGGGTAATAAGGAATGAGCAGTTCTTCGGGCCA	CSVGGVIRNEQFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	7	1	9	25	33	40	34	49													Vb 4	CSVGGVIRNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGTAGGGAGGAGTTCCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	3.4830136105454935E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	1	4	5	6	25	32	43	37	49													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGAGGGGGCTGACTAGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	3.4830136105454935E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	0	10	2	8	25	33	42	35	50													Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCAAGGGACAGAGGAGTGACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	3.7509377344336085E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	0	5	12	4	7	25	32	43	36	50													Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGGCGAATCTGGAAACACCATATATTTTGGAGAG	CSVDGESGNTIYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	3	9	0	1	1	3	25	36	40	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDGESGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGAGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSVAEGGQETQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	0	2	4	0	25	35	-1	39	46													Vb 4	CSVAEGGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGCCGGTGGAAACACCATATATTTTGGAGAG	CSVVAGGNTIYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	4	9	0	3	1	3	25	35	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVAGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGGTCCCTATGGCTACACCTTCGGTTCG	CSVEDGPYGYTF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	0	0	10	4	1	3	25	39	42	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDGPYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGACAACCGAAATCAGCCCCAGCATTTTGGTGAT	CSVGDNRNQPQHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	6	4	0	5	25	-1	41	35	46													Vb 4	CSVGDNRNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCTCTTTTGGCTATGGCTACACCTTCGGTTCG	CSVVSFGYGYTF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	4	0	10	4	8	0	25	35	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVSFGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGAACCCTGGAAACACCATATATTTTGGAGAG	CSVAGNPGNTIYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	4	0	8	2	2	3	25	35	41	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAGNPGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCACCTCCACGGGGGGGGGTCCGGGGACCCAGTACTTCGGGCCA	CSATSTGGGPGTQYF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	0	7	9	8	25	32	49	41	57													Vb 4	CSATSTGGGPGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGCAGTGGGGGGGACTGAAGCTTTCTTTGGACAA	CSAAVGGTEAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	0	5	7	0	25	32	-1	39	46													Vb 4	CSAAVGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGCCGGTGGGTGAAAAACTGTTTTTTGGCAGT	CSVGGPVGEKLFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	6	0	7	0	7	25	-1	41	35	48													Vb 4	CSVGGPVGEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGATCCCCGCCGGCAATGAGCAGTTCTTCGGGCCA	CSVRIPAGNEQFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	6	1	8	6	2	10	25	33	38	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRIPAGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACAGGGGGCTAGGTCAGCCCCAGCATTTTGGTGAT	CSVEDRGLGQPQHF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	0	6	0	4	25	-1	47	39	51													Vb 4	CSVEDRGLGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTCTGAGGGACTAAACACAGATACGCAGTATTTTGGCCCA	CSVEDSEGLNTDTQYF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	9	2	6	2	25	39	52	45	54						01,02							Vb 4	CSVEDSEGLNTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGACAGGGGGGAGCACTGAAGCTTTCTTTGGACAA	CSVETGGSTEAFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	0	3	25	-1	45	36	48													Vb 4	CSVETGGSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCCCGGGGAGCAAAGGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	5.894330725538528E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	3	6	4	9	25	34	43	38	52						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGACAGGGAGGAAAGACCCAGTACTTCGGGCCA	CSVEGQGGKTQYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	3	6	0	5	25	-1	45	38	50													Vb 4	CSVEGQGGKTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAAAGGTCCGGGACAGCGCTCCGGGGAGCTGTTTTTTGGAGAA	CSVKGPGQRSGELFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	6	9	4	25	33	49	42	53													Vb 4	CSVKGPGQRSGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAAGCCTACAGGGGACTGAAGCTTTCTTTGGACAA	CSGSLQGTEAFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	5	7	0	25	32	-1	39	46													Vb 4	CSGSLQGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTCCCTCGACAGAACAGCTTTCTTTGGACAA	CSVDSLDRTAFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	10	7	3	25	36	48	43	51													Vb 4	CSVDSLDRTAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGAGGTTGGGGGAACTCTGAAGCTTTCTTTGGACAA	CSVGGWGNSEAFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	6	6	1	6	8	4	25	33	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGWGNSEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAACTACGAGCAGTACTTCGGGCCG	CSVETGNYEQYF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	3	0	2	25	-1	43	37	45													Vb 4	CSVETGNYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAGGGGATTCACCGGGGAGCTGTTTTTTGGAGAA	CSVDRGFTGELFF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	4	0	3	25	-1	42	36	45													Vb 4	CSVDRGFTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGGCAGGACAGGGGTACGAGCAGTACTTCGGGCCG	CSAAGQGYEQYF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	2	4	5	0	25	32	-1	37	46													Vb 4	CSAAGQGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAAGATCCGGGACAGGGTACCGGGGAGCTGTTTTTTGGAGAA	CSVKDPGQGTGELFF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	5	9	1	25	33	51	42	52													Vb 4	CSVKDPGQGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAGGGGACCGGGGAGACCCAGTACTTCGGGCCA	CSVEEGTGETQYF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	0	5	0	7	25	-1	42	36	49													Vb 4	CSVEEGTGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCAGGGCTCTGGGGCGACCGAGCAGTACTTCGGGCCG	CSVQGSGATEQYF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	6	1	12	25	33	39	34	51													Vb 4	CSVQGSGATEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCTCCTTAAGGTAAGGGGGCCCACACACTGAAGCTTTCTTTGGACAA	CSVVSLR*GGPHTEAFF	Stop	VDJ	1	35	9.377344336084021E-4		51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	3	13	4	25	35	55	48	59													Vb 4	CSVVSLR*GGPHTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCACCCGGACAGACCAAGAGACCCAGTACTTCGGGCCA	CSTRTDQETQYF	In	VDJ	1	45	0.001205658557496517	0.001507487186358916	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	1	5	0	4	0	25	31	-1	35	41													Vb 4	CSTRTDQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCACAGACAGGGAGGCACGAAAAACTGTTTTTTGGCAGT	CSAQTGRHEKLFF	In	VDJ	2	49	0.001312828207051763	0.0016414860473685973	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	3	8	4	6	25	32	43	36	49													Vb 4	CSAQTGRHEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGGAGTTAGCTCTGGAAACACCATATATTTTGGAGAG	CSVVGVSSGNTIYF	In	VDJ	3	88	0.002357732290215411	0.002947974942212991	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	9	2	0	1	4	25	35	41	36	45													Vb 4	CSVVGVSSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGATAGCTCTGGAAACACCATATATTTTGGAGAG	CSVDDSSGNTIYF	In	VDJ	3	95	0.0025452791769370914	0.0031824729489799337	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	5	8	0	3	0	25	36	-1	39	42						01,02							Vb 4	CSVDDSSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTATTTGGGACAGGGTGCTGAAGCTTTCTTTGGACAA	CSVYLGQGAEAFF	In	VDJ	4	112	0.003000750187546887	0.0037519681082710797	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	6	5	2	25	34	48	39	50													Vb 4	CSVYLGQGAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATAGGACAGTTTGGAAAACTGTTTTTTGGCAGT	CSVIGQFGKLFF	In	VDJ	4	127	0.003402636373379059	0.004254463837057385	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	10	3	5	25	34	43	37	48													Vb 4	CSVIGQFGKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCCGACAGGGTAAGGGTCAGCCCCAGCATTTTGGTGAT	CASSPRQGKGQPQHF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	45	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	6	4	6	22	34	45	38	51														CASSPRQGKGQPQHF+TCRBV07-01+TCRBJ01-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTTACTAGCGGAAACACAGATACGCAGTATTTTGGCCCA	CASSFTSGNTDTQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	5	2	2	3	22	35	45	37	48						01,02								CASSFTSGNTDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGQGNTEAFF	In	VDJ	2	53	0.001419997856607009	0.0017754849083782788	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	1	2	0	22	34	-1	36	45														CASSPGQGNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDGNSNQPQHF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	3	0	0	1	23	-1	42	37	43													Vb 12	CASSDGNSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCAGTCAGGGGGCTATCAGCCCCAGCATTTTGGTGAT	CASSQSGGYQPQHF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	5	0	1	23	-1	47	40	48													Vb 12	CASSQSGGYQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTGTTGGGGGCCACTGAAGCTTTCTTTGGACAA	CASSELLGATEAFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	6	0	4	4	0	23	39	-1	43	49													Vb 12	CASSELLGATEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATGGGTCCAGGGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSDGSRGNNSPLHF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	1	5	6	1	23	37	50	43	51													Vb 12	CASSDGSRGNNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCATCAGTGAGCTGGCAGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CAISELAGGNEKLFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	1	4	4	0	23	38	-1	42	49													Vb 12	CAISELAGGNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAACACCCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEHPSSYNEQFF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	0	5	0	23	37	-1	42	46						01,02							Vb 12	CASSEHPSSYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSEGSGNTIYF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	2	0	10	0	0	0	23	-1	-1	38	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEGSGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAACAGGGGGCGGTAAATGAAAAACTGTTTTTTGGCAGT	CASSEQGAVNEKLFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	0	5	0	4	23	-1	46	37	50													Vb 12	CASSEQGAVNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGAAGGGACTATGGCTACACCTTCGGTTCG	CASRGRDYGYTF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	6	0	8	3	0	4	23	-1	38	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRGRDYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSELGGYEQYF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	3	1	0	23	39	-1	40	46													Vb 12	CASSELGGYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCCCCAGTATGTGAAGGATTTACGGTATGGCTACACCTTCGGTTCG	CASPQYVKDLRYGYTF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	48	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	8	1	8	5	14	7	23	32	49	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASPQYVKDLRYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATCACCGGGACCCTGGAACTGTTTTTTGGCAGT	CASITGTLELFF	In	VDJ	1	46	0.0012324509698853285	0.0015409869016113362	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-04	01	7	0	7	12	5	5	23	33	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASITGTLELFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGACTAGGACAGAGGAACACTGAAGCTTTCTTTGGACAA	CASRLGQRNTEAFF	In	VDJ	1	47	0.00125924338227414	0.0015744866168637566	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	4	2	23	34	44	38	46													Vb 12	CASRLGQRNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATCCAAATCAGCCCCAGCATTTTGGTGAT	CASSDPNQPQHF	In	VDJ	3	88	0.002357732290215411	0.002947974942212991	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	6	4	2	0	23	37	-1	39	41													Vb 12	CASSDPNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATCGTCAGGGGAGGTACGAGCAGTACTTCGGGCCG	CASSDRQGRYEQYF	In	VDJ	4	142	0.0038045225592112314	0.00475695956584369	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	3	4	2	4	4	3	23	37	47	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDRQGRYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTCCGGACTTCTAGATAATTCACCCCTCCACTTTGGGAAC	CASSGLLDNSPLHF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	10	1	10	5	5	5	24	31	41	36	46						01,02							Vb 12	CASSGLLDNSPLHF+TCRBV10-03+TCRBJ01-06	TCRBV10-03*01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGGACAGCTATCAGCCCCAGCATTTTGGTGAT	CASSEDSYQPQHF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	5	5	0	2	24	-1	44	39	46													Vb 12	CASSEDSYQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCGCAGGTTTGGCACAGATACGCAGTATTTTGGCCCA	CASRRFGTDTQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	4	4	1	4	4	24	31	39	35	43													Vb 12	CASRRFGTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGGGGGGCAGTACCATGATTACACCTTCGGTTCG	CAISGGQYHDYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	11	0	11	24	-1	43	37	54													Vb 12	CAISGGQYHDYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTACGACAGGGAAGCATGGCTACACCTTCGGTTCG	CAISTTGKHGYTF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	6	2	4	24	36	45	38	49													Vb 12	CAISTTGKHGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGTGCGCTAGCGGGGTCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASALAGSVTGELFF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	4	3	4	5	5	24	31	45	36	50													Vb 12	CASALAGSVTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTGGAAGGGGGAAGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSILEGGRTNEKLFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	5	1	1	5	3	27	42	53	47	56			01,02										Vb 17	CASSILEGGRTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCAGACTATTTAGAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSPRLFRGQETQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	9	2	5	9	27	38	48	43	57			01,02			01,02							Vb 17	CASSPRLFRGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCTGAGGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	2.679241238881149E-4		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	5	2	1	5	0	27	40	-1	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACACCGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSITPGQGTDTQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	4	1	5	0	27	42	-1	47	55			01,02										Vb 17	CASSITPGQGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGACAGCCCTACGAGCAGTACTTCGGGCCG	CASSIRQPYEQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	2	1	1	27	42	48	43	49			01,02										Vb 17	CASSIRQPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCTTTCGGGACCGAAAAACATTCAGTACTTCGGCGCC	CASSIGLSGPKNIQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	1	0	7	4	7	2	27	43	55	50	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGLSGPKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGTTAGCGGGGGTTGGGACAGATACGCAGTATTTTGGCCCA	CASSIGLAGVGTDTQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	3	5	5	27	41	55	46	60			01,02										Vb 17	CASSIGLAGVGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAATCTTCGGCACTGAAGCTTTCTTTGGACAA	CASSMGTIFGTEAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	4	1	8	27	41	48	42	56			01,02										Vb 17	CASSMGTIFGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGTCTGGGGGGGCGCGGAGTGAACAATGAGCAGTTCTTCGGGCCA	CASSLGLGGRGVNNEQFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	5	8	10	27	39	54	47	64			01,02										Vb 17	CASSLGLGGRGVNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCTTGGGCTCCTTGGGGGCTACACCTTCGGTTCG	CASNLGLLGGYTF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	8	0	8	5	8	27	37	46	42	54			01,02										Vb 17	CASNLGLLGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGACAGGTAAAACTTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	16	4.286785982209838E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	4	6	1	7	27	40	48	41	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTGGGACAGGGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSAGTGGTNTEAFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	1	3	3	27	39	53	42	56			01,02										Vb 17	CASSAGTGGTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGGCTGGGGACCCAGTACTTCGGGCCA	CASSTGLGTQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	7	0	5	27	-1	45	40	50			01,02										Vb 17	CASSTGLGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGGTTTACGAGCGGCTACACCTTCGGTTCG	CASSIGGFTSGYTF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	6	1	8	0	9	27	-1	48	43	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGFTSGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCCTTTATCGGGGGGTGGGCAGCCCCAGCATTTTGGTGAT	CASSPLSGGGQPQHF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	8	8	1	7	10	4	27	36	53	46	57			01,02										Vb 17	CASSPLSGGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGATGCAGGGCCCTTGAACACCATATATTTTGGAGAG		Out	VDJ	1	18	4.822634229986068E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	3	7	4	6	27	38	47	42	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACAAGGGATCATTTTATGAAAAACTGTTTTTTGGCAGT	CASSDKGSFYEKLFF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	0	8	6	5	7	27	39	48	44	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDKGSFYEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCAGGGGGATCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSAGGSTNEKLFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	1	0	1	2	27	39	47	40	49			01,02										Vb 17	CASSAGGSTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACTCGTCGGACCCCAAGGCAGCTCTGGCTACACCTTCGGTTCG	CASSILVGPQGSSGYTF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	1	7	7	6	13	27	42	52	48	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSILVGPQGSSGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTAGCATAGAGACCCAGTACTTCGGGCCA	CASSIGSIETQYF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	7	4	1	2	27	43	48	44	50			01,02			01,02							Vb 17	CASSIGSIETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGGGGTCAGCGACGTATCAGCCCCAGCATTTTGGTGAT	CASSITGSATYQPQHF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	3	5	1	10	27	42	48	43	58			01,02										Vb 17	CASSITGSATYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCCAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSMPGLNTEAFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	0	2	1	27	41	48	43	49			01,02										Vb 17	CASSMPGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCAGGGAGGTCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSAREVGTGELFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	4	4	4	27	39	49	43	53			01,02										Vb 17	CASSAREVGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGTAGGTGGGGGTAACTACAATGAGCAGTTCTTCGGGCCA	CAVGGGNYNEQFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	11	6	1	3	6	3	27	33	44	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAVGGGNYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTTCGAGCGGGCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	6.966027221090987E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	4	1	6	2	27	41	53	47	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCTTCGGGGGGCTATAGGACTGAAGCTTTCTTTGGACAA	CASASGGYRTEAFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	1	5	4	7	27	36	47	40	54			01,02										Vb 17	CASASGGYRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTGACAGGGACGATCTTTAAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	27	7.233951344979101E-4		56	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	0	3	12	25	37	47	40	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGGGGGTTACACTGAAGCTTTCTTTGGACAA	CASSLGGYTEAFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	6	1	3	3	2	27	39	47	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLGGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAACCAGGGGCATGGCGGGGAGCTGTTTTTTGGAGAA	CASSINQGHGGELFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	7	3	5	27	42	51	45	56			01,02										Vb 17	CASSINQGHGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGACAGGGGGCTACGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	8.037723716643446E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	0	4	2	5	27	41	54	43	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCCCAGGGTACTCTTGAGGGTGCAGATACGCAGTATTTTGGCCCA	CASAQGTLEGADTQYF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	4	3	4	3	14	27	36	44	39	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAQGTLEGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACTTCGGACTAGCGGGGACCTACGAGCAGTATTTCGGGCCG	CASSNFGLAGTYEQYF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	16	5	15	27	40	57	45	72			01,02										Vb 17	CASSNFGLAGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTAAGGGAGGGAGTTAAGTCACCCCTCCACTTTGGGAAC	CASSMLREGVKSPLHF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	9	0	10	5	7	27	41	53	46	60			01,02										Vb 17	CASSMLREGVKSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSMGMNTEAFF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	0	1	0	27	41	-1	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGACCCCGGGCTCACAAGAGACCCAGTACTTCGGGCCA	CASSTPGSQETQYF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	8	8	0	2	8	3	27	36	48	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPGSQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTTTCAAGTCCGGGACAGGGGGGCTCGGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	9.91319258386025E-4		56	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	1	3	11	8	25	34	56	45	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASSMGGNTEAFF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	8	0	1	0	2	27	-1	45	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTGAAGAGGATCCCGTCCTGGGCAGTACTTCGGGCCG		Out	VDJ	1	39	0.001044904083163648		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	11	1	9	7	12	27	37	48	44	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCCGGGACAGGATAACTATGGCTACACCTTCGGTTCG	CASSGPGQDNYGYTF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	1	5	1	27	39	52	44	53			01,02										Vb 17	CASSGPGQDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTTGGGGGGTCGCCTGTTTTTTGGCAGT		Out	VDJ	1	41	0.001098488907941271		32	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	9	1	14	3	4	27	37	46	40	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGCTGGGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTLGVGANVLTF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	4	6	1	3	4	1	27	40	49	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTLGVGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGCCCTCGGGGCGGTGGATATACGCAGTATTTTGGCCCA	CASSISPRGGGYTQYF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	2	7	0	7	7	7	27	42	54	49	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISPRGGGYTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGACAGGGAGCCCCTGAAGCTTTCTTTGGACAA	CASSIGQGAPEAFF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	6	1	5	27	41	50	42	55			01,02										Vb 17	CASSIGQGAPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGTCGGCGGGAATTCACCCCTCCACTTTGGGAAC	CASKVGGNSPLHF	In	VDJ	1	46	0.0012324509698853285	0.0015409869016113362	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	7	4	7	6	0	27	37	-1	43	48			01,02			01,02							Vb 17	CASKVGGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAGGATTACAATGAGCAGTTCTTCGGGCCA	CATQDYNEQFF	In	VDJ	1	47	0.00125924338227414	0.0015744866168637566	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	4	4	4	2	2	27	34	40	36	42			01,02										Vb 17	CATQDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGGAAGAAGAATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	0.00125924338227414		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	0	1	8	4	2	7	27	44	49	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAAGGGCCCGACCCTACGAGCAGTACTTCGGGCCG	CASSIVRARPYEQYF	In	VDJ	2	48	0.0012860357946629514	0.001607986332116177	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	1	5	3	2	2	6	27	43	49	45	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVRARPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTGGGGAGGGAAGAAAAACTGTTTTTTGGCAGT	CASSILGREEKLFF	In	VDJ	2	49	0.001312828207051763	0.0016414860473685973	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	9	0	8	4	2	27	41	52	45	54			01,02										Vb 17	CASSILGREEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTGGTTATTATGGCTACACCTTCGGTTCG	CASSAGYYGYTF	In	VDJ	2	51	0.0013664130318293858	0.0017084854778734381	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	10	5	3	4	27	39	44	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAGYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAAACAGGGCTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	53	0.001419997856607009		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	2	3	2	27	39	48	42	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGGGCCAGTTGGGGGCGCGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	54	0.0014467902689958203		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	6	0	3	9	4	27	35	50	44	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCGGGGGCGAGGGAGACCCAGTACTTCGGGCCA	CASSIPGARETQYF	In	VDJ	2	57	0.0015271675061622548	0.0019094837693879603	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	6	0	5	3	4	27	41	50	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPGARETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGGTTAACACTGAAGCTTTCTTTGGACAA	CASSIEGVNTEAFF	In	VDJ	2	59	0.0015807523309398779	0.001976483199892801	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	6	1	2	0	2	27	-1	49	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCCGGGGATAGCAATCAGCYCCAGCATTTTGGTGAT	CASSISGDSNQXQHF	In	VDJ	2	59	0.0015807523309398779	0.001976483199892801	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	12	3	13	27	41	49	44	62			01,02										Vb 17	CASSISGDSNQXQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASRTGAGELFF	In	VDJ	2	61	0.0016343371557175008	0.0020434826303976418	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	6	0	0	27	-1	-1	38	46			01,02										Vb 17	CASRTGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGATCCGGGACAGCTTTTTCTGGAAACACCATATATTTTGGAGAG	CASSRSGTAFSGNTIYF	In	VDJ	2	62	0.0016611295681063123	0.002076982345650062	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	5	1	5	5	27	40	52	45	57			01,02										Vb 17	CASSRSGTAFSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAACGTTTACCAAGGCGATGAGCCCCAGCATTTTGGTGAT	CASRNVYQGDEPQHF	In	VDJ	2	78	0.002089808166327296	0.0026129777896887877	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	6	5	4	8	12	5	27	38	53	50	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRNVYQGDEPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACCTGACAGGGGGTTGTCAAAAACATTCAGTACTTCGGCGCC	CASRT*QGVVKNIQYF	Stop	VDJ	2	78	0.002089808166327296		48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	2	1	3	5	4	27	38	52	43	56			01,02										Vb 17	CASRT*QGVVKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGCCGGGGTACAGTGGAGCCCCAGCATTTTGGTGAT	CASSIEGRGTVEPQHF	In	VDJ	3	83	0.0022237702282713536	0.0027804763659508894	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	8	4	8	27	44	53	48	61			01,02										Vb 17	CASSIEGRGTVEPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCGTCAGGGGGCACCACTGAAGCTTTCTTTGGACAA	CASSISSGGTTEAFF	In	VDJ	3	84	0.002250562640660165	0.00281397608120331	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	4	5	2	27	41	54	46	56			01,02										Vb 17	CASSISSGGTTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSIGQNTEAFF	In	VDJ	3	90	0.002411317114993034	0.003014974372717832	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	8	0	1	1	1	27	41	46	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGACAATTTTCTAATCAGCCCCAGCATTTTGGTGAT	CASSIGQFSNQPQHF	In	VDJ	7	213	0.005706783838816847	0.007135439348765536	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	6	4	1	7	27	41	47	42	54			01,02										Vb 17	CASSIGQFSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACTCCGGACTAGCGGGGACCTACGAGCAGTACTTCGGGCCG	CASSNSGLAGTYEQYF	In	VDJ	7	239	0.006403386560925946	0.008006431945328464	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	2	5	1	27	40	57	45	58			01,02										Vb 17	CASSNSGLAGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGTCGGAGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASVGASSYEQYF	In	VDJ	10	308	0.008252063015753939	0.01031791229774547	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	6	6	0	5	2	27	36	45	41	47			01,02			01,02							Vb 17	CASVGASSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCATAAGGACAGGGGAAAGTAATGGCTACACCTTCGGTTCG	CASIRTGESNGYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	2	6	3	6	23	33	45	36	51													Vb 11	CASIRTGESNGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGGGACAGGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	4.018861858321723E-4		46	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	1	4	1	0	23	39	-1	40	51													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGAGGGGCAGCCGCCGGGTCTGGAAACACCATATATTTTGGAGAG	CASGGAAAGSGNTIYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	8	10	0	1	0	12	23	-1	38	32	50													Vb 11	CASGGAAAGSGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCGAACCCGGGGGGGGCCGAAGGAAACACCATATATTTTGGAGAG	CASSANPGGAEGNTIYF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	4	8	0	4	6	6	23	36	50	42	56													Vb 11	CASSANPGGAEGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAATTGGAACCTTCTATGGCTACACCTTCGGTTCG	CASSEIGTFYGYTF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	2	1	8	4	3	5	23	38	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEIGTFYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTAGGGCCGGACCTCGCTGAAGCTTTCTTTGGACAA	CASSVGPDLAEAFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	4	1	7	6	7	4	23	36	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSVGPDLAEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCCTGGACAGGAAATGGCTACACCTTCGGTTCG	CASSAWTGNGYTF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	6	3	2	23	36	46	39	48													Vb 11	CASSAWTGNGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCATTCCCTCGGATCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	6.698103097202872E-4		37	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	7	1	8	4	7	1	23	33	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCTCAATGGGGTTCAGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	8.305647840531562E-4		44	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	4	6	2	5	6	6	23	36	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAACCGGGACACCTTCCTCCTACGAGCAGTACTTCGGGCCG	CASSETGTPSSYEQYF	In	VDJ	2	49	0.001312828207051763	0.0016414860473685973	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	0	3	5	23	38	47	41	52													Vb 11	CASSETGTPSSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGTTGGTGGGGCATGAAGCTTTCTTTGGACAA	CASSEGLVGHEAFF	In	VDJ	2	51	0.0013664130318293858	0.0017084854778734381	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	7	0	7	8	1	23	38	51	46	52													Vb 11	CASSEGLVGHEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACGACAGGGTGGTCCTGGAAACACCATATATTTTGGAGAG	CASSERQGGPGNTIYF	In	VDJ	2	74	0.00198263851677205	0.0024789789286791064	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	3	2	1	5	23	38	46	39	51													Vb 11	CASSERQGGPGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCCAGCCTCTATGGCTACACCTTCGGTTCG	CASSESSLYGYTF	In	VDJ	4	118	0.0031615046618797557	0.003952966399785602	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	1	4	5	4	1	3	23	39	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESSLYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTGGGACAGGGGGCGCTTCTATGAGACCCAGTACTTCGGGCCA	CASSWDRGRFYETQYF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	0	5	1	8	23	35	48	36	56													Vb 22	CASSWDRGRFYETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCACCCTGGGAGCGTAGGGGGCTGAAGCTTTCTTTGGACAA	CATLGA*GAEAFF	Stop	VDJ	1	13	3.4830136105454935E-4		39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	5	1	6	12	0	23	30	-1	42	48													Vb 22	CATLGA*GAEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCGCTCGGGGGGCCCATGGCTACACCTTCGGTTCG	CASTARGAHGYTF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	1	6	5	3	23	33	45	38	48													Vb 22	CASTARGAHGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGAGAGATCAGGTCCGTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	14	3.7509377344336085E-4		46	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	4	3	7	5	23	34	45	41	50													Vb 22	X+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCCCTTTTGGGAGGGGACACCTGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	4.018861858321723E-4		55	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	1	8	9	23	35	50	43	59													Vb 22	X+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGGGACAGCTTGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSRDSLSSYNSPLHF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	5	0	1	6	23	35	43	36	49													Vb 22	CASSRDSLSSYNSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATTCCCCAGGGAAACTATGGCTACACCTTCGGTTCG	CASIPQGNYGYTF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	2	5	1	23	33	43	38	44													Vb 22	CASIPQGNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTCGAGTTACAGGGGAGGCGATGAGCAGTTCTTCGGGCCA	CASSSSYRGGDEQFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	8	8	5	23	34	49	42	54													Vb 22	CASSSSYRGGDEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCCGCCCCAGGGAGACCCAGTACTTCGGGCCA	CASSPRPRETQYF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	4	5	8	0	23	35	-1	43	47													Vb 22	CASSPRPRETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACCTATATAATTCACCCCTCCACTTTGGGAAC	CASNLYNSPLHF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	4	9	4	2	0	23	33	-1	35	38						01,02							Vb 22	CASNLYNSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACACAGCTTCACAGATACGCAGTATTTTGGCCCA	CASSEHSFTDTQYF	In	VDJ	2	48	0.0012860357946629514	0.001607986332116177	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	2	1	3	23	38	43	39	46													Vb 22	CASSEHSFTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGGGGCAGGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSGGRGSSYNSPLHF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	1	0	5	2	26	38	50	43	52														CASSGGRGSSYNSPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCTCGTTGGGCACTGAAGCTTTCTTTGGACAA	CASSLGTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	8	0	9	4	5	0	26	35	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAACCCTTTGACAGCCGCCTGGAAACACCATATATTTTGGAGAG	CASSETL*QPPGNTIYF	Stop	VDJ	1	11	2.947165362769264E-4		51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	5	2	10	4	26	38	53	48	57														CASSETL*QPPGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCATCCGACCCCCGACCGGGCCGGGTACTGAAGCTTTCTTTGGACAA	CAIRPPTGPGTEAFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	10	8	0	5	14	5	26	33	51	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRPPTGPGTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTACCAGCAGTCACCCCCACACTGGAAACCATATATTTTGGAGAG		Out	VDJ	1	13	3.4830136105454935E-4		40	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	5	1	8	10	12	1	26	38	53	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCAGGGTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	18	4.822634229986068E-4		44	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	3	1	0	0	26	-1	-1	41	46														X+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCTCTTCGGGGTGGCGAGCAGTTCTTCGGGCCA	CASSEALRGGEQFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	10	9	4	26	38	52	47	56														CASSEALRGGEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAAAGGTTTGATGAACACTGAAGCTTTCTTTGGACAA	CASSKGLMNTEAFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	42	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	5	5	4	0	2	5	26	38	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGLMNTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTTTGGGGGCCCACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	7.769799592755332E-4		49	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	6	0	0	2	3	26	42	50	44	53														X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTAGGGTTAAGGCGGACTGAAGCTTTCTTTGGACAA	CASSLGLRRTEAFF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	42	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	4	5	3	5	1	9	26	39	44	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLRRTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGAATCCGTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLESVTGELFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	9	5	6	0	19	35	-1	41	43						01,02								CASSLESVTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD02-01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTTCGCCGACAGGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	3.7509377344336085E-4		44	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	2	5	1	19	33	45	38	46														X+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTGATAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLIATNEKLFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	5	8	0	4	0	19	31	-1	35	38						01,02								CASSLIATNEKLFF+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01	TCRBD02-01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCGGCCAAGGGCCAGGGAACTATGGCTACACCTTCGGTTCG	CASGQGPGNYGYTF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	42	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	2	4	0	29	44	-1	48	53			01,02											CASGQGPGNYGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCGACAGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSPTGQNTEAFF	In	VDJ	2	60	0.0016075447433286892	0.0020099829151452213	42	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	1	2	29	42	50	43	52			01,02											CASSPTGQNTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GCCAGCAGAAAACCTTTTTGCGGTAATCCAGCCCTTTTTGATTAGGACGGACCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	98	0.002625656414103526		73	TCRBV21	TCRBV21-01	01				TCRBJ02	TCRBJ02-07	01	2	1	7	2	32	5	-1	12	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-01+TCRBJ02-07	TCRBV21-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCGGCCCGGGACAGGGGACCACTGAAGCTTTCTTTGGACAA	CASSGPGQGTTEAFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	4	6	2	26	37	53	43	55		TCRBV10-01,TCRBV10-02												CASSGPGQGTTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYGTGTATCTCTGTGCTAGCAGCCTCAATCTAGCGGGGGGCTTAGATACGCAGTATTTTGGCCCA	CASSLNLAGGLDTQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	1	5	6	3	19	31	48	37	51		TCRBV07-02,TCRBV07-05												CASSLNLAGGLDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACGCCGGACAGGGCTGGAACACTGAAGCTTTCTTTGGACAA	CASSYAGQGWNTEAFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	1	3	3	26	41	52	44	55		TCRBV06-05,TCRBV06-06,TCRBV06-07												CASSYAGQGWNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGGAGTCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGVHTGELFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	11	2	3	0	3	19	-1	38	35	41		TCRBV07-05,TCRBV07-07												CASSLGVHTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCCCCGGGACAGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	11	2.947165362769264E-4		44	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	4	3	1	26	43	53	46	54		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCATGTCACAGCCCAATCAGCCCCAGCATTTTGGTGAT	CASMSQPNQPQHF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	39	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	5	3	4	2	22	32	40	36	42		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASMSQPNQPQHF+TCRBV12-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCCAGGGGTAGGTAACTATGGCTACACCTTCGGTTCG	CASSPGVGNYGYTF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	1	1	4	19	31	38	32	42		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSPGVGNYGYTF+TCRBV05-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTGGAACCCCGCCCGGCTAGCAGCAGATACGCAGTATTTTGGCCCA	CASSWNPARLAADTQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	7	4	14	2	22	35	54	49	56		TCRBV07-04,TCRBV07-06				01,02								CASSWNPARLAADTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTYRGCTGTGTATCTCTGTGCTAGCAGCTTATCACAGAACACTGAAGCTTTCTTTGGACAA	CASSLSQNTEAFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	6	1	4	0	22	35	-1	39	42		TCRBV07-01,TCRBV07-04												CASSLSQNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYRTGTATCKCTGTGCCAGAAGCTCACAGGGGGCGCCCCTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	3.7509377344336085E-4		44	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	0	9	1	5	18	31	41	32	46		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGGAAGCTGGGCTATAATTCACCCCTCCACTTTGGGAAC	CASRKLGYNSPLHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	6	0	9	3	6	0	26	37	-1	43	46		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKLGYNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTCCTGTTGGGACAGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	15	4.018861858321723E-4		49	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	4	1	8	0	18	30	-1	38	46		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTTACAGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASSLQGGEKLFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	4	3	3	7	1	3	23	36	43	37	46		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGAGTTCTGGGAACACTGAAGCTTTCTTTGGACAA	CASSYSSSGNTEAFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	2	1	0	6	28	-1	48	45	54		TCRBV06-04,TCRBV06-08												CASSYSSSGNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAACCAGGACTAGCGGACTTTACAATGAGCAGTTCTTCGGGCCA	CASRTRTSGLYNEQFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	5	4	5	4	23	34	49	39	53		TCRBV06-07,TCRBV06-08				01,02								CASRTRTSGLYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGTTGACAGGAGAGATTCACCCCTCCACTTTGGGAAC	CASSVDRRDSPLHF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	4	8	3	4	23	35	44	38	48		TCRBV06-07,TCRBV06-08												CASSVDRRDSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCGTATCTGGAAACACCATATATTTTGGAGAG	CASSVSGNTIYF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	36	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	5	9	1	2	0	23	34	-1	36	38		TCRBV06-04,TCRBV06-08				01,02								CASSVSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCCCACCAGGGGTGAAAAACTGTTTTTTGGCAGT	CASTPTRGEKLFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	2	7	7	0	26	36	-1	43	49		TCRBV06-07,TCRBV06-08												CASTPTRGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGGAAGGCGGGGTACTGTCCCGCCCCAGCATTTTGGTGAT	CASSLGRRGTVPPQHF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	7	3	9	4	9	19	35	45	39	54		TCRBV11-01,TCRBV11-03												CASSLGRRGTVPPQHF+TCRBV11-X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCTCCGGGACAGGGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	27	7.233951344979101E-4		47	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	5	4	0	24	39	-1	43	53		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCCGGGACAACGAAGGGGAAAAACTGTTTTTTGGCAGT	CASSRDNEGEKLFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	8	1	8	18	30	37	31	45		TCRBV07-04,TCRBV07-06												CASSRDNEGEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTACCCTGAGGAGATTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	38	0.0010181116707748366		47	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	2	0	6	2	18	33	43	39	45		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGTGGGACAGGGGCTAACCTACGAGCAGTACTTCGGGCCG	CASSLVGQGLTYEQYF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	2	1	4	19	35	46	36	50		TCRBV11-01,TCRBV11-03												CASSLVGQGLTYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTATTTCCGGGGGAGAAAGGCCCCAGCATTTTGGTGAT	CASSISGGERPQHF	In	VDJ	2	53	0.001419997856607009	0.0017754849083782788	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	2	9	5	6	23	35	46	40	52		TCRBV06-07,TCRBV06-08												CASSISGGERPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTCCCGCGGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	68	0.0018218840424391813		41	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	7	5	4	3	0	24	37	-1	40	44		TCRBV06-05,TCRBV06-06,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCACCGAGCAGGGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	69	0.0018486764548279928		38	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	4	2	2	5	0	23	30	-1	35	41		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAATGGGGGTCAGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSEWGSGNNSPLHF	In	VDJ	2	70	0.0018754688672168042	0.0023449800676694247	48	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	2	4	3	5	7	1	24	39	51	46	52		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEWGSGNNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGGGAGCCAGGGGGGCAATGGCTACACCTTCGGTTCG	CASSLGSQGGNGYTF	In	VDJ	3	84	0.002250562640660165	0.00281397608120331	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	6	5	3	19	35	47	40	50		TCRBV11-01,TCRBV11-03												CASSLGSQGGNGYTF+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCAGACCACTATGGCTACACCTTCGGTTCG	CASSSDHYGYTF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	2	7	3	4	1	26	37	44	41	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDHYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTGGGGGTTTGGGTAACTGAAGCTTTCTTTGGACAA	CASSLGVWVTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	6	1	5	3	8	26	37	45	40	53		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVWVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATGCAATCCGGGCGCGCCGGCGAGCAGTACTTCGGGCCG	CASSMQSGRAGEQYF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	8	0	6	9	7	26	38	51	47	58		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMQSGRAGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGGAGTAAGCGAGCAGTACTTCGGGCCG	CASSLGGVSEQYF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	2	6	1	4	26	42	48	43	52		TCRBV12-03,TCRBV12-04												CASSLGGVSEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCGGGACATATGGCTACACCTTCGGTTCG	CASSQGGTYGYTF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	0	6	5	2	0	26	42	-1	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGGATTTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	9	2.411317114993034E-4		37	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	1	8	5	2	3	26	40	45	42	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTGTCAGGGGGCGAAGGAGAAAAACTGTTTTTTGGCAGT	CASSLSGGEGEKLFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	8	5	6	22	33	46	38	52		TCRBV12-03,TCRBV12-04												CASSLSGGEGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATGCGAACACTGAAGCTTTCTTTGGACAA	CAISDANTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	36							TCRBJ01	TCRBJ01-01	01	5	2	8	1	0	3	23	-1	37	35	40	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDANTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAGATGAGGAGGACTCTGGAAACACCATATATTTTGGAGAG	CASSQDEEDSGNTIYF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	10	1	0	3	1	19	36	44	39	45	TCRBV03,TCRBV07	TCRBV03-01,TCRBV03-02,TCRBV07-05												CASSQDEEDSGNTIYF+X+TCRBJ01-03		TCRBD02-01*02	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACGGACAGGGTTACCCCTGGTACTGAAGCTTTCTTTGGACAA	CASSPTDRVTPGTEAFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	5	4	11	26	39	51	43	62		TCRBV03-01,TCRBV03-02												CASSPTDRVTPGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGGGGGACTCGCTATGGCTACACCTTCGGTTCG	CASRGTRYGYTF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	0	10	4	1	2	26	37	44	38	46	TCRBV03,TCRBV12					01,02								CASRGTRYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGCTCTGCCCGGACTAGCGGGGGGCGAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSSARTSGGRGDNEQFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	5	9	7	22	32	55	41	62	TCRBV08,TCRBV24													CASSSARTSGGRGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGAAGACAGGGGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	10	2.679241238881149E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	2	6	2	0	22	33	-1	35	43	TCRBV09,TCRBV12													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGATCCTCTCGGGACAACTAATCCTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	2.679241238881149E-4		52	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	6	5	9	9	22	33	48	42	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCRGCYSTGTAYYTCTGTGCCAGCAGGGTACCCTTCAGTCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	10	2.679241238881149E-4		53	unresolved						TCRBJ01	TCRBJ01-02	01	6	2	7	4	23	0	22	33	-1	56	59	TCRBV05,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGGTCCCGGGACAGGGACTTACGAGCAGTACTTCGGGCCG	CASSGPGTGTYEQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	6	3	22	34	49	40	52	TCRBV09,TCRBV12													CASSGPGTGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTATGGGGGGGAAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	10	2.679241238881149E-4		43	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	9	0	5	1	2	22	37	45	38	47		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTTTTGTAAGCGGCTACGAGCAGTACTTCGGGCCG	CASSFVSGYEQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	6	5	3	4	0	22	36	-1	40	45	TCRBV09,TCRBV12					01,02								CASSFVSGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GSGACTCRGCYSTGTAYYTCTGTGCCAAGGACCAACAGGGGGCGCTTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.679241238881149E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	3	0	4	7	4	19	26	42	33	46	TCRBV07,TCRBV13													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTAGGCATGAGGACTGAAGCTTTCTTTGGACAA	CASSLGMRTEAFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	1	5	4	0	18	34	-1	38	42	TCRBV03,TCRBV07													CASSLGMRTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCACCGGGGGTTCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	2.679241238881149E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	2	1	2	4	18	30	38	32	42	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTGGGGACACCGGATCACAGATACGCAGTATTTTGGCCCA	CASSWGHRITDTQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	6	2	1	6	18	31	38	32	44	TCRBV05,TCRBV11													CASSWGHRITDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGTCCCTCAGGGATTTGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	2.679241238881149E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	3	5	5	18	29	39	34	44	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGACGGACAGTGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASRRTVGSTDTQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	0	2	5	22	33	41	35	46	TCRBV03,TCRBV07													CASRRTVGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAACCTGGCGGGACAGCTGACCGAGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	2.679241238881149E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	5	7	10	23	33	47	40	57	TCRBV09,TCRBV21													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAAGGGCCTAGCGGTAATGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	2.679241238881149E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	5	5	7	5	23	39	53	46	58	TCRBV09,TCRBV21					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCCTACCAGATGGCGCGACTGAAGCTTTCTTTGGACAA	CASSPLPDGATEAFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	6	4	5	5	8	8	26	37	48	45	56	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLPDGATEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAGCAGGCAGGGAACTATGGCTACACCTTCGGTTCG	CASSEQAGNYGYTF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	2	7	0	22	34	-1	41	46		TCRBV12-03,TCRBV12-04												CASSEQAGNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCCCAGGAGGGGGCCAGGACTGAAGCTTTCTTTGGACAA	YASSPQEGARTEAFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	5	7	4	22	34	48	41	52	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPQEGARTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCAGCCGGGTCTCCGTCGAAACTGTTTTTTGGCAGT	CASSPAGSPSKLFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	11	5	9	19	31	40	36	49		TCRBV05-06,TCRBV05-07				01,02								CASSPAGSPSKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD02-01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGACCGAAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGPKSTDTQYF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	TCRBV05						TCRBJ02	TCRBJ02-03	01	0	2	7	0	0	5	19	-1	38	35	43		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPKSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAATCTTGGTACGGGACTAGCGGGGTCTAAAGGCATTCAGTACTTCGGCGCC	CASSENLGTGLAGSKGIQYF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	60	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	0	3	9	11	8	21	36	60	47	68		TCRBV06-01,TCRBV06-08												CASSENLGTGLAGSKGIQYF+TCRBV06-X+TCRBJ02-04	TCRBV06	TCRBD02-01*01	TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCTCGGGAAGGGGGCGATGAACACTGAAGCTTTCTTTGGACAA	CASSLGKGAMNTEAFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	0	7	2	26	38	52	45	54		TCRBV12-03,TCRBV12-04												CASSLGKGAMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGKGACTCKGCYSTGTATYTCTGTGCCAGCAGCCGAAAAGGGTCAGGGAGCCCCTACGAGCAGTACTTCGGGCCG	CASSRKGSGSPYEQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	4	4	3	2	9	4	26	39	53	48	57	TCRBV03,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRKGSGSPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGGGATAGGGCCTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	3.2150894866573784E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	6	1	9	26	35	41	36	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACGGAGGCGGTTAAGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	3.2150894866573784E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	1	6	3	8	23	35	43	38	51	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTGGCAAGCCACGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCACCCGCAATAGCCAAAAACATTCAGTACTTCGGCGCC	VPPAIAKNIQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	24	3	10	0	0	17	45	-1	42	39	59		TCRBV24-01,TCRBV24-or09_02				01,02								VPPAIAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGGTCCAGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQGPGQGNTEAFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	1	9	0	18	30	-1	39	47	TCRBV07,TCRBV11													CASSQGPGQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCTCCTTGGGCAAATCCACTGAAGCTTTCTTTGGACAA	CASSSSLGKSTEAFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	4	7	5	18	31	42	38	47	TCRBV05,TCRBV11													CASSSSLGKSTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCAAGCTCCGGGACAGGGATACGAGCAGTACTTCGGGCCG	CASSQAPGQGYEQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	8	1	22	34	51	42	52	TCRBV07,TCRBV11													CASSQAPGQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGAGGACTCRGCCRTGTAYKTCTGTGCCAGCAGCTTGGCCGTGATGGGCATGATATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	3.2150894866573784E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	8	0	5	12	4	23	34	50	46	54	TCRBV02,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCGGGGACAGGGGTTAGGAGAGCAGTACTTCGGGCCG	CASRRGQGLGEQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	7	3	6	26	37	50	40	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRGQGLGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGAAAAAAACATTCAGTACTTCGGCGCC	CASSQGEKNIQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	39	TCRBV03						TCRBJ02	TCRBJ02-04	01	1	0	8	4	0	1	26	-1	46	42	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGEKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCAGGTCAGCTATGGCTACACCTTCGGTTCG	CASSQGQVSYGYTF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	4	2	4	26	42	48	44	52		TCRBV03-01,TCRBV03-02												CASSQGQVSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGGGGGATCTGGAAACACCATATATTTTGGAGAG	CASSRGGSGNTIYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	5	1	1	1	1	26	39	46	40	47		TCRBV03-01,TCRBV03-02												CASSRGGSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAATCCACAGGGGTTTCATGGCTACACCTTCGGTTCG	CSASNPQGFHGYTF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	2	6	6	4	26	37	50	43	54		TCRBV20-01,TCRBV20-or09_02												CSASNPQGFHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAGSSAMWCAGCTKTGTACTTCTGTGCCAGCAGTCTCCCAGGGGAAAGTATACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLPGESIPSTDTQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	13	4	2	0	13	11	25	28	47	41	58	TCRBV12,TCRBV22													CASSLPGESIPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCTCGGGACAGACCTATTATGAAAAACTGTTTTTTGGCAGT	CASSSGQTYYEKLFF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	6	3	7	22	33	43	36	50	TCRBV12,TCRBV21													CASSSGQTYYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCCGGGACGGACTAAATTCACCCCTCCACTTTGGGAAC	CASRDGLNSPLHF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	8	1	9	7	6	0	22	31	-1	37	43	TCRBV09,TCRBV12					01,02								CASRDGLNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTACGAGGGTACAGCAAGCTTTCTTTGGACAA		Out	VDJ	1	13	3.4830136105454935E-4		38	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	9	3	6	24	37	45	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGTCCCGGGACAGGGAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	3.4830136105454935E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	5	6	1	18	30	45	36	46	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTACAGGGCAGTAATGAAAAACTGTTTTTTGGCAGT	CASSVQGSNEKLFF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	4	2	3	24	36	44	38	47	TCRBV09,TCRBV21													CASSVQGSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGGAGTCTCCGGGACAGCTGAAGCTTTCTTTGGACAA	CASSGVSGTAEAFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	6	9	0	26	38	-1	47	54	TCRBV02,TCRBV12													CASSGVSGTAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTACCCGGACAGGGGGCTTGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSTRTGGLSNEKLFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	0	3	4	4	24	36	51	40	55	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSTRTGGLSNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAAGGCGGATAATTCACCCCTCCACTTTGGGAAC	CASSPKADNSPLHF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	7	5	5	5	0	26	39	-1	44	48		TCRBV03-01,TCRBV03-02				01,02								CASSPKADNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGTTGAAGGGGCCCTCCACTTTGGGAAC	CASSLVEGALHF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	5	2	14	7	0	26	39	-1	46	51		TCRBV03-01,TCRBV03-02												CASSLVEGALHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACACAGGGGGTGATTGAGCAGTTCTTCGGGCCA	CSATQGVIEQFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	1	9	3	4	26	34	45	37	49		TCRBV20-01,TCRBV20-or09_02												CSATQGVIEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTCCCAACGAACACTGAAGCTTTCTTTGGACAA	CSARLPTNTEAFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	3	7	1	6	0	26	38	-1	44	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLPTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCCCCCTTGGCGCAAGACCAGAGACCCAGTACTTCGGGCCA	CASSLFPLGARPETQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	51	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	2	7	4	19	1	24	36	58	55	59		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFPLGARPETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGACGGAACCTCCTACGAGCAGTACTTCGGGCCG	CASSLDGTSYEQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	1	7	0	2	5	24	36	42	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGTSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTGAAAACCGAAACACCATATATTTTGGAGAG	CASSENRNTIYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	36	unresolved						TCRBJ01	TCRBJ01-03	01	2	3	7	5	1	1	23	38	41	39	42	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENRNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTCCCGGACGGCAGGGCAGTCGTATGGCTACACCTTCGGTTCG	CASSRTAGQSYGYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	3	5	10	6	23	32	47	42	53	TCRBV06,TCRBV10													CASSRTAGQSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGGAGGGGTCGCCGTTAAAACCAAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	3.7509377344336085E-4		50	unresolved						TCRBJ01	TCRBJ01-02	01	6	5	2	4	1	17	18	29	35	30	52	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCCCAAGCCGCCACAGATACGCAGTATTTTGGCCCA	CASSPQAATDTQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	7	2	5	3	19	31	39	36	42	TCRBV07,TCRBV11					01,02								CASSPQAATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCAAGATCACAGGGGGGATTCACCCTTCCACTTTGGGAAC	CASSQDHRGDSPFHF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	1	17	7	10	19	31	46	38	56	TCRBV03,TCRBV05,TCRBV07													CASSQDHRGDSPFHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGCAACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLATGGSYEQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	1	0	1	0	22	39	-1	40	48	TCRBV07,TCRBV11													CASSLATGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGTAACGGCGACAGGGGGCTTTTTGGCTACACCTTCGGTTCG	CASNGDRGLFGYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	0	7	8	4	24	31	49	39	53	TCRBV02,TCRBV21													CASNGDRGLFGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGGACAGGGGTATTCACCCCTCCACTTTGGGAAC	CASSPGQGYSPLHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	2	8	3	1	26	37	50	40	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGQGYSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGACAGTTGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSHDSWGNTEAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	1	1	6	26	40	46	41	52		TCRBV03-01,TCRBV03-02												CASSHDSWGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAACTATGGCTACACCTTCGGTTCG	CASSQNYGYTF	In	VJ	1	15	4.018861858321723E-4	5.024957287863053E-4	33	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	0	0	2	0	1	26	-1	40	-1	41		TCRBV03-01,TCRBV03-02												CASSQNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGCCAGGAGGTCAAGAGACCCAGTACTTCGGGCCA	CASSPGPGGQETQYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	7	0	2	1	8	26	39	45	40	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGATCCAGGGGGGCCGAGAGACCCAGTACTTCGGGCCA	CSAKIQGGRETQYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	1	4	7	4	26	34	48	41	52		TCRBV20-01,TCRBV20-or09_02												CSAKIQGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCGGACAGCTCCCTCCAGATACGCAGTATTTTGGCCCA	CSARIGQLPPDTQYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	5	4	3	7	26	38	47	41	54		TCRBV20-01,TCRBV20-or09_02												CSARIGQLPPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCAGACCGATATGAGCAGTTCTTCGGGCCA	CSASPDRYEQFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	2	7	8	4	4	26	37	44	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPDRYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGATTAAGCGGGGAGACCTACAATGAGCAGTTCTTCGGGCCA	CASRLSGETYNEQFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	6	3	2	4	3	24	35	46	39	49		TCRBV24-01,TCRBV24-or09_02												CASRLSGETYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCAACGGTGGAGGCACTGAAGCTTTCTTTGGACAA	CASSNGGGTEAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	1	4	7	0	24	35	-1	42	47	TCRBV24,TCRBV27													CASSNGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGATGGGGGGCGATAATTCACCCCTCCACTTTGGGAAC	CASRMGGDNSPLHF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV24						TCRBJ01	TCRBJ01-06	01	7	6	0	5	4	1	24	35	45	39	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMGGDNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTACTCGCAGTGGTCGCTACAAGCTTTCTTTGGACAA	CASSYSQWSLQAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	6	4	5	9	6	10	24	36	45	42	55	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSQWSLQAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGAAGGGGTAGGGGTTCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	4.018861858321723E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	2	0	2	9	18	32	39	34	48	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCCCGTGGTTGGCTACACCTTCGGTTCG	CASSQGPVVGYTF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	0	10	7	7	1	26	42	51	49	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGPVVGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGGACAGGAAGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CSAGTGRGMNTEAFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	0	1	8	26	34	43	35	51		TCRBV20-01,TCRBV20-or09_02												CSAGTGRGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACAGGGGGCAGACCTACGAGCAGTACTTCGGGCCG	CSANRGQTYEQYF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	0	2	0	3	26	-1	45	36	48		TCRBV20-01,TCRBV20-or09_02												CSANRGQTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCCGCTCTGGGGAAGCTTTCTTTGGACAA	CSARDGRSGEAFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	9	8	10	0	26	40	-1	50	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGRSGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACAGGGGCGATCCAGCATTTTGGTGAT	CSARDGTGAIQHF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	2	12	1	4	26	40	51	41	55		TCRBV20-01,TCRBV20-or09_02												CSARDGTGAIQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGGGCCTCGGCGAACACTGAAGCTTTCTTTGGACAA	CASRASANTEAFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	9	0	1	0	6	22	-1	36	33	42	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRASANTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGCTGGGGCTTCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSLLGLPQSRANVLTF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	7	0	5	3	12	22	36	44	39	56		TCRBV12-03,TCRBV12-04												CASSLLGLPQSRANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCRGCCATGTATCKCTGTGCCACCGAGGTCAGGGGGACTAGCGGGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CATEVRGTSGGGSYEQYF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	0	2	0	11	3	19	26	51	37	54	TCRBV07,TCRBV11													CATEVRGTSGGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGCCCAGGACAAGTTCGGTACACCTTCGGTTCG		Out	VDJ	1	16	4.286785982209838E-4		41	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	6	11	6	7	19	33	44	39	51		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGACGGACAGGGCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	4.554710106097953E-4		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	4	3	2	26	37	48	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCATGGGACAGGAAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	4.554710106097953E-4		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	7	6	5	26	38	52	44	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTTGGTGCCGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	4.554710106097953E-4		44	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	5	3	8	0	26	39	-1	47	50		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGCCTGATACGCAGTATTTTGGCCCA	CASSLRPDTQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	36	TCRBV12						TCRBJ02	TCRBJ02-03	01	2	5	4	6	0	3	26	-1	44	41	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAATGGCCTAGGTGGGACTGAAGCTTTCTTTGGACAA	CASSQNGLGGTEAFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	4	8	5	6	5	26	41	51	47	56		TCRBV03-01,TCRBV03-02				01,02								CASSQNGLGGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGACAGAGATGAACACTGAAGCTTTCTTTGGACAA	CSATTEMNTEAFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	0	1	3	26	36	42	37	45		TCRBV20-01,TCRBV20-or09_02												CSATTEMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAGGGCCAATACTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	4.554710106097953E-4		47	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	2	0	10	24	-1	44	39	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTTTGGTAATTCACCCCTCCACTTTGGGAAC	CASSFFGNSPLHF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV24						TCRBJ01	TCRBJ01-06	01	6	0	10	6	6	0	24	36	-1	42	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFFGNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCCCTTTGTTAGGTCCCGACGCTGGGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	17	4.554710106097953E-4		50	unresolved						TCRBJ01	TCRBJ01-04	01	8	6	1	8	21	0	23	32	-1	53	58	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGGCCAAACGGGGGGGCTCAGATACGCAGTATTTTGGCCCA	CASSLAKRGGSDTQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	4	5	2	19	35	48	40	50	TCRBV05,TCRBV07													CASSLAKRGGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTTATACTGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLYWAGELFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	9	6	6	0	22	35	-1	41	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYWAGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGGACAGGGAGGCACTGAGCAGTTCTTCGGGCCA	CASGQGGTEQFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	3	9	0	6	23	-1	40	32	46	TCRBV09,TCRBV21													CASGQGGTEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCACACCGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSHTGSGANVLTF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	45	TCRBV12						TCRBJ02	TCRBJ02-06	01	5	3	6	0	1	4	26	38	42	39	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTGSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGGGAGACCCAGTACTTCGGGCCA	CASSLRETQYF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	5	5	0	0	26	-1	-1	41	44		TCRBV12-03,TCRBV12-04				01,02								CASSLRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGGTTTCCCACGGCCTAGTTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	18	4.822634229986068E-4		56	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	4	8	1	13	1	18	32	49	45	50	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGRGGACTCRGCYSTGTATCTCTGTGCCAGCAGCTTAAGGGGACAGGGAATGGCTTTCTTTGGACAA	CASSLRGQGMAFF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	11	2	4	22	37	48	39	52	TCRBV05,TCRBV07													CASSLRGQGMAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCAACAGGGGACCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSATGDPSTDTQYF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	0	3	5	24	36	46	39	51	TCRBV09,TCRBV21													CASSATGDPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGGTAAGGGCAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSVGKGRLNTEAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	48	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	4	4	0	12	1	26	37	53	49	54		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGKGRLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGACTCCGCGGGGGGGCAACGAGCAGTTCTTCGGGCCA	CASRTPRGGNEQFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	10	6	4	26	37	52	43	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRTPRGGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACATATCAAACCCAGGGGGCGAGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	5.090558353874183E-4		52	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	0	4	12	3	26	36	56	48	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCTTTTTGGGGGTGATGGCTACACCTTCGGTTCG	CSARVLFGGDGYTF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	6	1	6	8	2	26	39	52	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVLFGGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACAGGGGGATCAGCCCCAGCATTTTGGTGAT	CSAGQGDQPQHF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	1	5	0	0	26	-1	-1	35	45		TCRBV20-01,TCRBV20-or09_02												CSAGQGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCTTGACTAGGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTLTRGGTGELFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	9	0	4	9	0	22	32	-1	41	48		TCRBV12-03,TCRBV12-04												CASTLTRGGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGAAGCAAGGAGAGGGCGAGCAGTACTTCGGGCCG	CASRKQGEGEQYF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	6	10	0	22	33	-1	43	48		TCRBV12-03,TCRBV12-04												CASRKQGEGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTTACCCGGCCGAACACTGAAGCTTTCTTTGGACAA	CASSEFTRPNTEAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	45	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	9	0	1	7	1	23	38	48	45	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEFTRPNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
YSKMSSASWCAKCYRTGTACTTSTGTGCCAGCAGTTTTGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGGNQPQHF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	unresolved						TCRBJ01	TCRBJ01-05	01	5	6	2	2	3	0	23	35	-1	38	42	TCRBV02,TCRBV06			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGTAGCTACGCTATCCGATGAGCAGTTCTTCGGGCCA	CASSVATLSDEQFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	8	0	9	23	-1	42	39	51	TCRBV02,TCRBV09					01,02								CASSVATLSDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGGTAGGAAACACCATATATTTTGGAGAG	CSASVGNTIYF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	8	5	4	2	2	26	34	39	36	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSASVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTAGGCCCCGGACATCATTTCTACGAGCAGTACTTCGGGCCG	CSALGPGHHFYEQYF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	6	3	10	6	26	34	49	44	55		TCRBV20-01,TCRBV20-or09_02												CSALGPGHHFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAACGGGACGAGCAGTACTTCGGGCCG	CSASQRDEQYF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	5	4	0	26	37	-1	41	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSASQRDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTTCGACAGGGGGAGCGTGAAAAACTGTTTTTTGGCAGT	CSAVRQGEREKLFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	1	7	4	4	26	35	48	39	52		TCRBV20-01,TCRBV20-or09_02												CSAVRQGEREKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGGACCCTCTAGGAATGAAAAACTGTTTTTTGGCAGT	CSVGPSRNEKLFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	7	1	7	5	2	8	26	33	39	35	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVGPSRNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACAGGTCTATAATTCACCCCTCCACTTTGGGAAC	CAISEQVYNSPLHF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	4	3	0	1	23	-1	42	38	43	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISEQVYNSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTGCCGGGGCTTGACAGGGGGACTGAAGCTTTCTTTGGACAA	CASSLPGLDRGTEAFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	5	10	0	18	32	-1	42	51	TCRBV05,TCRBV07													CASSLPGLDRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCCCGGACAGCTAGTAATGAAAAACTGTTTTTTGGCAGT	CASSARTASNEKLFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	4	4	4	18	30	40	34	44	TCRBV07,TCRBV11													CASSARTASNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCACCCTCGTGACAGGGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSTLVTGGGETQYF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	0	5	8	3	19	31	49	39	52	TCRBV05,TCRBV11													CASSTLVTGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAGCGCGTGTAGCTCGAGAGACCCAGTACTTCGGGCCA	CASSEARVARETQYF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	7	4	10	3	26	38	52	48	55	TCRBV02,TCRBV12					01,02								CASSEARVARETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAAGCTAACTCTGACAGGGAAATATGGCTACACCTTCGGTTCG	CASKLTLTGKYGYTF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	3	5	10	3	26	36	53	46	56		TCRBV03-01,TCRBV03-02												CASKLTLTGKYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAAGTCAACGGGCAGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	5.626406601650412E-4		47	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	8	0	1	9	3	26	38	51	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCCCGGGACAGGTGGAACACTGAAGCTTTCTTTGGACAA	CSARDARDRWNTEAFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	4	1	5	2	26	40	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDARDRWNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGACAGGGGAAACCCTACGAGCAGTACTTCGGGCCG	CSARPGQGKPYEQYF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	2	3	4	26	37	50	40	54		TCRBV20-01,TCRBV20-or09_02												CSARPGQGKPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTCTACTAGCGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSSTSGSYNEQFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	2	3	2	0	23	36	-1	38	49	TCRBV06,TCRBV27													CASSSTSGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTTGACAGGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGRTGELFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	5	3	3	18	29	39	32	42	TCRBV07,TCRBV11													CASSLTGRTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGAGGGGACAGGGGAGATCGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	5.626406601650412E-4		55	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	2	1	3	7	19	35	48	38	55		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTTGCAGGGGGCTCAAATGAAAAACTGTTTTTTGGCAGT	CASSVAGGSNEKLFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	5	5	3	26	37	50	42	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVAGGSNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGAGGACAGGGGCGACACGAACACTGAAGCTTTCTTTGGACAA	CASREDRGDTNTEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	1	3	6	26	37	49	40	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASREDRGDTNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAGGCAGGAGGGACCCAGTACTTCGGGCCA	CASSEAGGTQYF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	1	7	6	0	26	38	-1	44	49	TCRBV09,TCRBV12													CASSEAGGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATCCCAACAGCTATGGCTACACCTTCGGTTCG	XASSQDPNSYGYTF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	4	5	0	23	40	-1	45	49	TCRBV01,TCRBV04													XASSQDPNSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTACCGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTGDSNQPQHF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	0	2	1	24	36	43	38	44	TCRBV06,TCRBV10													CASSTGDSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACGGGACAGAGGAACACTGAAGCTTTCTTTGGACAA	CASSTGQRNTEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	1	2	2	26	38	47	40	49		TCRBV03-01,TCRBV03-02												CASSTGQRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTGGACAGGGGGCTTAGGTTGTCCTTCGGGCCA	CASSQGVDRGLRLSF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02			1	1	0	18	4	10	26	42	57	46	67		TCRBV03-01,TCRBV03-02						TCRBJ02-01,TCRBJ02-05						CASSQGVDRGLRLSF+TCRBV03-X+TCRBJ02-X	TCRBV03	TCRBD01-01*01	TCRBJ02	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGACAGCCAGAGCACTATGGCTACACCTTCGGTTCG	CASSQGQPEHYGYTF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	3	0	7	26	-1	47	40	54		TCRBV03-01,TCRBV03-02												CASSQGQPEHYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTCCACAGGGTTCGTCTCCGGGGAGCTGTTTTTTGGAGAA	CASSSTGFVSGELFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	6	3	7	26	38	47	41	54	TCRBV03,TCRBV07													CASSSTGFVSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGACTAGCGGCAATGAGCAGTTCTTCGGGCCA	CSAETSGNEQFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	6	3	0	26	34	-1	37	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAETSGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGCAGGATTGAACACTGAAGCTTTCTTTGGACAA	CSASWAGLNTEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	0	5	2	26	37	46	42	48		TCRBV20-01,TCRBV20-or09_02												CSASWAGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGGCGGCAATGAACACTGAAGCTTTCTTTGGACAA	CSAQAAMNTEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	4	4	0	0	6	26	-1	39	35	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQAAMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCACACAGGTGAACTATGGCTACACCTTCGGTTCG	CSASTQVNYGYTF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	4	2	5	2	26	35	45	40	47		TCRBV20-01,TCRBV20-or09_02												CSASTQVNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCGAGGGGCGCTCTGGAAACACCATATATTTTGGAGAG	CSVEGRSGNTIYF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	7	5	2	0	3	2	26	33	41	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVEGRSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGCAGGGGGAAAAACTGTTTTTTGGCAGT	CATSEGQGEKLFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	2	8	4	0	24	38	-1	42	48		TCRBV24-01,TCRBV24-or09_02												CATSEGQGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCTGCCCGAGGTTGGGACAACTACTCTGGAAACACCATATATTTTGGAGAG	CATSARGWDNYSGNTIYF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	0	6	0	13	4	24	33	52	46	56		TCRBV24-01,TCRBV24-or09_02												CATSARGWDNYSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTTTAGGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSFFRGENTEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	5	1	1	6	2	24	36	48	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFFRGENTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGAGCAGGCGCTACCCGCGAAGCTTTCTTTGGACAA	CASSLGAGATREAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	1	4	4	8	3	10	18	34	41	37	51	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLGAGATREAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTATTTGACAGGGTCGGTAACTATGGCTACACCTTCGGTTCG	CASSLFDRVGNYGYTF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	1	6	4	24	36	49	42	53	TCRBV09,TCRBV21													CASSLFDRVGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTACTTCTGTGCCACCAGTGTGGAGGTTGAGGCGACTGGGGACTTTCAAGAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	5.894330725538528E-4		64	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	1	18	8	7	20	44	38	52		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATGGTACAGGGGGATGGGGACTATGGCTACACCTTCGGTTCG	CASSQMVQGDGDYGYTF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	1	3	5	6	26	41	54	46	60		TCRBV03-01,TCRBV03-02												CASSQMVQGDGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGCCTCCTCTAGGGAGACCCAGTACTTCGGGCCA	CASSQVASSRETQYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	4	8	5	9	1	26	42	55	51	56		TCRBV03-01,TCRBV03-02				01,02								CASSQVASSRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGAGGGGGTCAGCTAACTATGGCTACACCTTCGGTTCG	CASSRRGSANYGYTF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	5	1	0	2	4	26	39	47	41	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRGSANYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGGACCAGGTTGAAAAACTGTTTTTTGGCAGT	CSARDRDQVEKLFF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	0	7	7	2	5	26	40	47	42	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRDQVEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTAAGCGGGGGGAGGGGTGAGCAGTTCTTCGGGCCA	CSARLSGGRGEQFF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	1	9	4	5	26	37	50	41	55		TCRBV20-01,TCRBV20-or09_02												CSARLSGGRGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATGAGAGGCGTATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSASMRGVSGANVLTF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	3	11	1	1	5	4	26	37	46	42	50		TCRBV20-01,TCRBV20-or09_02												CSASMRGVSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATGACGGAGAACACTGAAGCTTTCTTTGGACAA	CASMTENTEAFF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	11	1	8	1	7	0	24	31	-1	38	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMTENTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTATCGGGACAGGGGGAACCACAGATACGCAGTATTTTGGCCCA	CASSIGTGGTTDTQYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	1	2	3	3	26	38	52	41	55	TCRBV06,TCRBV10													CASSIGTGGTTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCCTGAAGACAGCAGCTTCTACATCTGCAGTCGGGCTCTCACTACTTGGGGCAGAGAGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	23	6.162254849426642E-4		56	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	7	0	0	16	6	25	31	52	47	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCCGACAGGGGGCGAGGTATGGACTGAAGCTTTCTTTGGACAA	CASTPTGGEVWTEAFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	0	5	4	9	26	36	50	40	59		TCRBV03-01,TCRBV03-02												CASTPTGGEVWTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCCGCGCGGGGGGCAAGAAGGAAACACCATATATTTTGGAGAG	CSAPPRGGQEGNTIYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	7	1	4	8	6	26	34	50	42	56		TCRBV20-01,TCRBV20-or09_02												CSAPPRGGQEGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGAGACAGGGGAACTACGAGCAGTACTTCGGGCCG	CSARDQRQGNYEQYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	3	5	2	26	40	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDQRQGNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTTCAGGGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CSARFQGETGELFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	1	5	3	2	26	38	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSARFQGETGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGCAGGGACAGGGCGAATCGGCTACACCTTCGGTTCG	CASSVAGTGRIGYTF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	8	7	6	22	33	49	40	55	TCRBV09,TCRBV12													CASSVAGTGRIGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGAAAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEERDTGELFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	42	TCRBV12						TCRBJ02	TCRBJ02-02	01	5	5	3	3	6	0	22	34	-1	40	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEERDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGGACGAATTCACCCCTCCACTTTGGGAAC	CASSGTNSPLHF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	36	TCRBV24						TCRBJ01	TCRBJ01-06	01	5	1	7	7	0	1	24	-1	41	37	42		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGTNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGTCCTCGCGTCCCTGAAGCTTTCTTTGGACAA	CASSSPRVPEAFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	6	6	7	3	26	38	48	45	51		TCRBV12-03,TCRBV12-04				01,02								CASSSPRVPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCTTTGCCCAGGGGGCCAATGAGCAGTTCTTCGGGCCA	CSALFAQGANEQFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	6	9	0	26	35	-1	44	52		TCRBV20-01,TCRBV20-or09_02												CSALFAQGANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTCCGGGACAGGTGGGAAACACCATATATTTTGGAGAG	CSVPGQVGNTIYF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	4	4	4	2	26	33	45	37	47		TCRBV20-01,TCRBV20-or09_02												CSVPGQVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGACAGAAAAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	25	6.698103097202872E-4		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	5	0	1	5	24	42	49	43	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAAGGGGATGGGCCCCTCCACTTTGGGAAC	CASSQGDGPLHF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	5	2	13	2	5	26	38	45	40	50		TCRBV12-03,TCRBV12-04												CASSQGDGPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGACAGGGCGAACTGAAGCTTTCTTTGGACAA	CASSQRTGRTEAFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	5	1	3	26	41	50	42	53		TCRBV03-01,TCRBV03-02												CASSQRTGRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGGGGAAGGGTTACGAGCAGTACTTCGGGCCG	CASSQDPGKGYEQYF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	4	2	6	26	43	50	45	56		TCRBV03-01,TCRBV03-02												CASSQDPGKGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGGGCAAGGTAACACTGAAGCTTTCTTTGGACAA	CASSPRGQGNTEAFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	6	0	2	3	5	26	39	48	42	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGQGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCCCCTTGCCACAGATACGCAGTATTTTGGCCCA	CSAREPLATDTQYF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	10	0	2	0	7	26	-1	42	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREPLATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACTCAGGGGGTTTCAATGAGCAGTTCTTCGGGCCA	CSADSGGFNEQFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	6	4	3	26	35	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSADSGGFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGGGGGCCAAGAATGAGCAGTTCTTCGGGCCA	CASSSGGAKNEQFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	7	2	5	24	36	46	38	51		TCRBV24-01,TCRBV24-or09_02												CASSSGGAKNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCCGCCGGGACAGGGTCTTTTGTCTGTGAACACTGAAGCTTTCTTTGGACAA	CASSPPPGQGLLSVNTEAFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	60	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	0	8	11	21	33	50	41	61		TCRBV24-01,TCRBV24-or09_02												CASSPPPGQGLLSVNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATTCCCCCATCAGGGGGAGGCACCTACGAGCAGTACTTCGGGCCG	CASSQIPPSGGGTYEQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	2	10	5	26	41	58	51	63		TCRBV03-01,TCRBV03-02												CASSQIPPSGGGTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCTCACTAGCGGGGGAACCTCAGAGACCCAGTACTTCGGGCCA	CSARALTSGGTSETQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	3	2	4	5	6	26	39	55	44	61		TCRBV20-01,TCRBV20-or09_02												CSARALTSGGTSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGCGGGGGGCCAACGCACAGATACGCAGTATTTTGGCCCA	CSARGLAGGQRTDTQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	2	1	1	0	5	26	-1	52	39	57		TCRBV20-01,TCRBV20-or09_02												CSARGLAGGQRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGCTAGCGGGGGACGAGCAGTACTTCGGGCCG	CSARSLAGDEQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	5	3	0	26	38	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSARSLAGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGGGACTCAAGAGACCCAGTACTTCGGGCCA	CSARGTGTQETQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	2	1	3	26	37	47	38	50		TCRBV20-01,TCRBV20-or09_02												CSARGTGTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCACCGGGACAGGGGTCTAATTCACCCCTCCACTTTGGGAAC	CSASPGQGSNSPLHF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	6	5	2	26	35	50	40	52		TCRBV20-01,TCRBV20-or09_02												CSASPGQGSNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTAAACCGGGAAAACTTCTACCTTCGGGCCA		Out	VDJ	1	27	7.233951344979101E-4		37	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02			6	8	3	18	6	10	24	36	47	42	57		TCRBV24-01,TCRBV24-or09_02						TCRBJ02-01,TCRBJ02-05						X+TCRBV24-X+TCRBJ02-X	TCRBV24	TCRBD02-01*02	TCRBJ02	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTCAGGGAGTGGGGAGATACGCAGTATTTTGGCCCA	CASSLVREWGDTQYF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	4	3	5	5	7	24	36	46	41	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVREWGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTCCCGCAGTTATAATGAAAAACTGTTTTTTGGCAGT	CASSFSRSYNEKLFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	5	4	8	3	24	36	47	44	50		TCRBV24-01,TCRBV24-or09_02												CASSFSRSYNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGACCTAAAACAGGGAAATGGCTACACCTTCGGTTCG	CASSLDLKQGNGYTF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	6	6	2	18	35	47	41	49	TCRBV07,TCRBV11													CASSLDLKQGNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGCCGGGACACCTTTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	27	7.233951344979101E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	9	3	4	24	36	45	39	49	TCRBV12,TCRBV21													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAAGTGAGCACATAAGACTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASK*AHKTE*KTYGYTF	Stop	VDJ	1	27	7.233951344979101E-4		54	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	4	13	11	23	33	50	46	61	TCRBV09,TCRBV21					01,02								CASK*AHKTE*KTYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAACAGGGACCTCCGGCGGTGAGCAGTTCTTCGGGCCA	CASSRTGTSGGEQFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	9	2	11	26	39	47	41	58		TCRBV03-01,TCRBV03-02												CASSRTGTSGGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGACAGGCAATCTATGGCTACACCTTCGGTTCG	CSARPGQAIYGYTF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	4	2	4	26	38	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSARPGQAIYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGGACAGGGGGATTCAATCAGCCCCAGCATTTTGGTGAT	CSARGGTGGFNQPQHF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	1	3	2	3	26	39	52	41	55		TCRBV20-01,TCRBV20-or09_02												CSARGGTGGFNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCAGCGGCAGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CSAGSGRGMNTEAFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	0	8	1	26	35	50	43	51		TCRBV20-01,TCRBV20-or09_02												CSAGSGRGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TTTCTGTGCCAGCAGCCAAGGGAAATTGAGAGGCAGGCTGAGCTTTGATGGGGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	28	7.501875468867217E-4		68	TCRBV03						TCRBJ01	TCRBJ01-06	01	1	4	4	6	13	16	4	20	37	33	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGGGACACTGAAGCTTTCTTTGGACAA	CSARDRDTEAFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	3	0	0	26	-1	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSARDRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGCGGGCCAGAACACTGAAGCTTTCTTTGGACAA	CASSAGQNTEAFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	4	8	0	1	1	2	23	36	41	37	43	TCRBV02,TCRBV12			TCRBD01,TCRBD02										CASSAGQNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTTAAACCGGGACAGGGGGCACCCTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	8.037723716643446E-4		53	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	0	4	8	5	26	36	56	44	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGACAGGGGGCATAGATACGCAGTATTTTGGCCCA	CSASRTGGIDTQYF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	0	5	2	2	26	37	50	39	52		TCRBV20-01,TCRBV20-or09_02												CSASRTGGIDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCAGAGGGTGAAGGGGGCGTAACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	30	8.037723716643446E-4		55	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	0	7	10	4	24	42	59	52	63		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCATGAGGCTCGCAAACCACTACAATGAGCAGTTCTTCGGGCCA	CASMRLANHYNEQFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	11	1	3	4	11	24	31	39	35	50	TCRBV24,TCRBV27													CASMRLANHYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCACGAGGATTAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	30	8.037723716643446E-4		56	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	1	5	2	18	18	30	36	32	54	TCRBV05,TCRBV11													X+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCCCACCCGGAGGGGCTATGGAGTTCTTCGGGCCA		Out	VDJ	1	30	8.037723716643446E-4		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	14	9	7	20	31	46	40	53	TCRBV11,TCRBV23													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASGACTCGGCCMTGTATCTCTGTGCCAGCAGCACCTCGGGACAGGGGTACGAGCAGTACTTCGGGCCG	CASSTSGQGYEQYF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	4	5	0	19	31	-1	36	46	TCRBV05,TCRBV11													CASSTSGQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGGGGGGAGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGGITGELFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	1	4	0	6	19	-1	39	32	45		TCRBV05-06,TCRBV05-07				01,02								CASSSGGGITGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCCTGTGACAGGGGAAAAACTGTTTTTTGGCAGT	CASSPVTGEKLFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	3	8	5	0	23	35	-1	40	47	TCRBV02,TCRBV09													CASSPVTGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACGGGACTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSTGLAGGTDTQYF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	1	3	0	26	37	-1	40	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTGLAGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCTAGGGGCGGACCTGCCTGAAGCTTTCTTTGGACAA	CASSLGADLPEAFF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	6	3	9	26	37	45	40	54	TCRBV12,TCRBV21													CASSLGADLPEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCCTCTCTAGGAGGGCTGGAGACCCAGTACTTCGGGCCA	CASSPPSLGGLETQYF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	5	12	3	26	38	56	50	59		TCRBV12-03,TCRBV12-04												CASSPPSLGGLETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAAATTAAATACCAGAAAGACCTATGGCTACACCTTCGGTTCG	CATSKLNTRKTYGYTF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	48	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	2	7	4	17	0	24	36	-1	53	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSKLNTRKTYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCRTGTATSKCTGTGCCAGCACCGCATCTATAACCTACAATGAGCAGTTCTTCGGGCCA	CASTASITYNEQFF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	9	2	6	3	18	28	37	34	40	TCRBV07,TCRBV11					01,02								CASTASITYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGACTGACCTACGAGCAGTACTTCGGGCCG	CASSRLTYEQYF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	2	1	2	26	38	43	39	45		TCRBV12-03,TCRBV12-04				01,02								CASSRLTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCACCCGGGACTAGCGGGGGGGACCGACACAGATACGCAGTATTTTGGCCCA	XASSHPGLAGGTDTDTQYF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	0	2	3	5	23	37	56	40	61	TCRBV01,TCRBV04,TCRBV07,TCRBV17													XASSHPGLAGGTDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAAGACAGGGGAAAGGCATACTGAAGCTTTCTTTGGACAA	CASKTGERHTEAFF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	2	5	1	8	26	36	45	37	53		TCRBV03-01,TCRBV03-02												CASKTGERHTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGACAGGCGACCCCTAACTATGGCTACACCTTCGGTTCG	CSARRGQATPNYGYTF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	0	2	6	26	38	48	40	54		TCRBV20-01,TCRBV20-or09_02												CSARRGQATPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCTTCAGGGGGCCCTTAACTATGGCTACACCTTCGGTTCG	CASSLALQGALNYGYTF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	1	4	3	18	35	47	39	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLALQGALNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTACGACGGTTGAGGTCCACTTTGGGAAC	CASSQGTTVEVHF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	1	17	11	0	26	42	-1	53	57		TCRBV03-01,TCRBV03-02												CASSQGTTVEVHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGGGAAAACACTGAAGCTTTCTTTGGACAA	CASSQVGENTEAFF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	6	1	2	1	2	26	42	48	43	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTACTAGACAGGGGGCTAAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	8.841496088307792E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	0	1	5	3	26	37	52	42	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGCGACTGAAGCTTTCTTTGGACAA	CSARDGATEAFF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	5	1	1	26	40	46	41	47		TCRBV20-01,TCRBV20-or09_02												CSARDGATEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGACAGGACTTCAATTCACCCCTCCACTTTGGGAAC	CSARQDFNSPLHF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	4	7	1	5	26	35	42	36	47		TCRBV20-01,TCRBV20-or09_02												CSARQDFNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACCCTAGCGGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASTLAGGSTDTQYF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	4	1	0	5	1	24	31	47	36	48	TCRBV12,TCRBV21													CASTLAGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGATTTTGGGACAGGGTTCGCCTTCGGTTCG	CASSVDFGTGFAF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	15	10	4	26	37	56	47	60		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVDFGTGFAF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCGACAGGGGGCTGAATGAGCAGTTCTTCGGGCCA	CASSPDRGLNEQFF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	7	3	2	26	38	51	41	53		TCRBV12-03,TCRBV12-04												CASSPDRGLNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGTCAGAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSASQRAGANVLTF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	11	0	2	6	0	26	34	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSASQRAGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAAGGGAGGAAGGTCCGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	9.109420212195906E-4		53				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	1	1	1	10	23	38	45	39	55	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												X+X+TCRBJ01-05		TCRBD02-01*02	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCTAAAATAGACGGGACAGGGCTCCTCCGAGCAGTACTTCGGGCCG	CASTLK*TGQGSSEQYF	Stop	VDJ	1	35	9.377344336084021E-4		51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	6	13	6	26	36	58	49	64		TCRBV03-01,TCRBV03-02												CASTLK*TGQGSSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGTTGTGAATGTAGCTTTCTTTGGACAA	CSAREGVVNVAFF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	10	0	10	26	-1	45	40	55		TCRBV20-01,TCRBV20-or09_02												CSAREGVVNVAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTAAGGGACAGGGGTATGGCTACACCTTCGGTTCG	CSAPKGQGYGYTF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	5	5	0	26	35	-1	40	50		TCRBV20-01,TCRBV20-or09_02												CSAPKGQGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGGGACGGCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGRLSGANVLTF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	48	TCRBV24						TCRBJ02	TCRBJ02-06	01	6	0	7	0	2	4	24	36	43	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRLSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTTTTCCAGGGCCAAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFFPGPRSSYEQYF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	0	5	8	18	32	42	37	50	TCRBV07,TCRBV11													CASSFFPGPRSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGCGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSFASSYNSPLHF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	7	6	0	1	2	26	40	44	41	46		TCRBV12-03,TCRBV12-04				01,02								CASSFASSYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCTCGGTCAGCCCCAGCATTTTGGTGAT	CASSLLGQPQHF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	8	5	6	4	0	26	39	-1	43	46		TCRBV03-01,TCRBV03-02				01,02								CASSLLGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCACAGCTCCTCAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	9.645268459972136E-4		47				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	5	2	6	7	24	36	46	42	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAAAACTAAGAAATTGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	9.645268459972136E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	3	9	1	2	8	18	33	39	35	47	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGTACCGGGGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLYRGAGNTEAFF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	1	3	4	19	34	44	37	48	TCRBV05,TCRBV07													CASSLYRGAGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGTTAGCGCGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	9.91319258386025E-4		44	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	6	1	4	2	26	41	50	45	52		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGGACAGGGGTTATCACCCCTCCACTTTGGGAAC	CSARDRGQGLSPLHF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	2	10	3	3	26	40	53	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDRGQGLSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGACAGGGTACCGCTATGGCTACACCTTCGGTTCG	CASSSTGYRYGYTF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	4	2	5	24	36	45	38	50		TCRBV24-01,TCRBV24-or09_02												CASSSTGYRYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAGGGGACAGAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGDRGGNQPQHF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	5	2	0	5	18	-1	41	34	46	TCRBV03,TCRBV11													CASSLGDRGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	YASSPGNTGELFF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	1	1	0	22	34	-1	35	39	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPGNTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCCCGGACAGGGGGCAGTGGGGATAATTCACCCCTCCACTTTGGGAAC	CASSVARTGGSGDNSPLHF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	0	5	3	7	23	39	53	42	60	TCRBV09,TCRBV21													CASSVARTGGSGDNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGACCGGTGATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTGDATNEKLFF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	48	unresolved						TCRBJ01	TCRBJ01-04	01	2	2	7	0	0	8	19	-1	36	33	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGDATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGGGACAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGTTSTDTQYF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	6	0	1	3	18	32	39	33	42	TCRBV05,TCRBV11													CASSLGTTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCGCCTACGAGCAGTACTTCGGGCCG	CASSQDPAYEQYF	In	VDJ	1	39	0.001044904083163648	0.0013064888948443939	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	6	2	3	0	26	43	-1	46	48		TCRBV03-01,TCRBV03-02				01,02								CASSQDPAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGACTAGCGTGGTGGGGGCCCAGTACTTCGGGCCA	CSARRTSVVGAQYF	In	VDJ	1	39	0.001044904083163648	0.0013064888948443939	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	6	9	1	9	26	38	48	39	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRTSVVGAQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGCAGGGTGAGGACTGAAGCTTTCTTTGGACAA	CSARDGRVRTEAFF	In	VDJ	1	39	0.001044904083163648	0.0013064888948443939	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	5	3	5	26	40	48	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDGRVRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGGAGGCGGCGGAATCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGGGIANTGELFF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	54	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	10	1	0	4	11	26	37	46	41	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGGGGIANTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGACAGGGTACTGGGAAACACCATATATTTTGGAGAG	CASSQDDRVLGNTIYF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	3	4	1	5	26	43	51	44	56		TCRBV03-01,TCRBV03-02												CASSQDDRVLGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTTCGCTTCCCATGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	0.0010716964955524595		50	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	4	6	5	10	9	26	39	51	49	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGAGTGGGGGATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	40	0.0010716964955524595		49	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	6	1	0	7	3	26	37	49	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTATTTAACGGCGGAACCTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	40	0.0010716964955524595		53	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	5	0	4	6	24	41	49	45	55	TCRBV24,TCRBV27					01,02								X+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCAATTGCCGCGGACAGGAGTCTCTAACTATGGCTACACCTTCGGTTCG	CASSQLPRTGVSNYGYTF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	4	0	11	5	23	34	52	45	57	TCRBV06,TCRBV10													CASSQLPRTGVSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGACCGCGCTACACCTTCGGTTCG	CASSLGPRYTF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	33	TCRBV12						TCRBJ01	TCRBJ01-02	01	3	0	7	9	0	3	26	-1	45	40	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPRYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGAGAGGGCCGTACTTTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSERAVLSYNSPLHF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	0	1	2	8	23	35	42	37	50	TCRBV01,TCRBV04													CASSERAVLSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAGTTGGGGACAGGGGTCATTGATCGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSELGTGVIDRLNTEAFF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	60	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	0	6	12	21	33	49	39	61		TCRBV12-03,TCRBV12-04												CASSELGTGVIDRLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCAGGGAGAACTAAGCCCTACGAGCAGTACTTCGGGCCG	CSAAGRTKPYEQYF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	4	3	2	2	10	26	34	41	36	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAGRTKPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGAGCCACCACCGGGGAGCTGTTTTTTGGAGAA	CSAREGATTGELFF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	2	4	0	4	26	-1	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSAREGATTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTAGATAAGGTAGATACGCAGTATTTTGGCCCA	CSASLDKVDTQYF	In	VDJ	1	41	0.001098488907941271	0.0013734883253492345	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	8	5	1	7	26	37	42	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLDKVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCGGGCGGGGGGAGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	0.001098488907941271		44	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	4	4	2	24	36	48	40	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTCACGCTGAAGCTTTCTTTGGACAA	CASSLHAEAFF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	33	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	3	7	6	5	1	26	37	44	42	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLHAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATTTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	42	0.0011252813203300824		35	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	6	0	26	38	-1	44	47		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGACAGGGTTCAATGAGCAGTTCTTCGGGCCA	CASSQEGTGFNEQFF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	6	1	2	26	43	53	44	55		TCRBV03-01,TCRBV03-02												CASSQEGTGFNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGCCGTGGGGAGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSAPWGGGANVLTF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	9	1	3	8	0	26	38	-1	46	52		TCRBV03-01,TCRBV03-02												CASSAPWGGGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01*02	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGGGGACAGCCATTCATGGGGCCCCAGCATTTTGGTGAT	CASSRGQPFMGPQHF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	9	3	11	26	37	47	40	58		TCRBV03-01,TCRBV03-02												CASSRGQPFMGPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGGGGGACAGCGTCCCTACGAGCAGTACTTCGGGCCG	CSASGGQRPYEQYF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	0	5	2	5	4	26	35	47	40	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGQRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAACCTTTCTGAGGACTAGCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	43	0.001152073732718894		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	1	7	1	10	0	26	30	-1	40	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGACCAACACTGAAGCTTTCTTTGGACAA	CSARKTNTEAFF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	7	2	3	1	26	37	43	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARKTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGACAGGGTTTTCTATGGCTACACCTTCGGTTCG	CSARDRVFYGYTF	In	VDJ	1	44	0.0011788661451077056	0.0014739874711064956	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	4	2	4	26	34	45	36	49		TCRBV20-01,TCRBV20-or09_02												CSARDRVFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACTCTAAGATAGACGGGACAGGGCTCCTCCGAGCAGTACTTCGGGCCG	CASTLR*TGQGSSEQYF	Stop	VDJ	1	45	0.001205658557496517		51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	6	13	6	26	36	58	49	64		TCRBV03-01,TCRBV03-02												CASTLR*TGQGSSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCGGACTAGCGGGGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	0.001205658557496517		46	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	1	2	3	1	26	35	52	38	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGGGACAGGGGTAATTCACCCCTCCACTTTGGGAAC	XASSRDRGNSPLHF	In	VDJ	1	45	0.001205658557496517	0.001507487186358916	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	6	1	0	22	34	-1	35	45	TCRBV01,TCRBV07,TCRBV17													XASSRDRGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCGAACAGGGGGGTAACTATGGCTACACCTTYGGTTCG	CSARPEQGGNYGYTF	In	VDJ	1	46	0.0012324509698853285	0.0015409869016113362	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	1	20	6	20	26	37	51	43	71		TCRBV20-01,TCRBV20-or09_02												CSARPEQGGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGCTTGGGACAGGTCTGGAAACACCATATATTTTGGAGAG	CASSAWDRSGNTIYF	In	VDJ	1	47	0.00125924338227414	0.0015744866168637566	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	4	1	4	0	22	34	-1	38	46	TCRBV09,TCRBV12													CASSAWDRSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCTGGGGACAAGAACCCGTGGCATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	47	0.00125924338227414		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	6	8	3	12	24	39	48	42	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATAGGGAACAGGGCCTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	48	0.0012860357946629514		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	2	7	4	26	41	54	48	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGTTTGGAGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLEVNTEAFF	In	VDJ	2	50	0.0013396206194405745	0.0016749857626210177	39							TCRBJ01	TCRBJ01-01	01	0	5	4	0	0	0	18	-1	-1	34	37	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEVNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAGGGGGCGCGGAACTGTTTTTTGGCAGT	CSASGGAELFF	In	VDJ	2	51	0.0013664130318293858	0.0017084854778734381	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	0	12	1	4	26	35	44	36	48		TCRBV20-01,TCRBV20-or09_02												CSASGGAELFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGTGGGGAAGAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSLWGRGGYYGYTF	In	VDJ	2	51	0.0013664130318293858	0.0017084854778734381	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	0	3	9	1	18	32	48	41	49	TCRBV07,TCRBV11													CASSLWGRGGYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGCCCGGGTTTTATATGGCTACACCTTCGGTTCG	CASSLARVLYGYTF	In	VDJ	2	52	0.0013932054442181974	0.0017419851931258583	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	4	5	1	5	18	35	40	36	45	TCRBV07,TCRBV11					01,02								CASSLARVLYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGTGGACAGGGGTACAGATACGCAGTATTTTGGCCCA	CASSFVDRGTDTQYF	In	VDJ	2	53	0.001419997856607009	0.0017754849083782788	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	2	3	3	1	26	40	52	43	53		TCRBV12-03,TCRBV12-04												CASSFVDRGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAGGACTAGCGGAACCTACGAGCAGTACTTCGGGCCG	CSARGRTSGTYEQYF	In	VDJ	2	53	0.001419997856607009	0.0017754849083782788	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	5	2	3	2	26	39	52	42	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGRTSGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCAAGATCACAGGGGGGATTCACCCCTCCACTTTGGGAAC	CASSQDHRGDSPLHF	In	VDJ	2	53	0.001419997856607009	0.0017754849083782788	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	1	8	2	1	18	35	45	37	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDHRGDSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAACCCAAACTACGGATACAGAGAAGCTTTCTTTGGACAA	CASNPNYGYREAFF	In	VDJ	2	55	0.0014735826813846319	0.0018424843388831194	42	TCRBV05						TCRBJ01	TCRBJ01-01	01	6	3	5	8	15	1	19	29	48	44	49		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPNYGYREAFF+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCAGAACTCTGGAAACACCATATATTTTGGAGAG	CSARGQNSGNTIYF	In	VDJ	2	56	0.0015003750937734434	0.0018759840541355398	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	5	0	2	2	26	39	44	41	46		TCRBV20-01,TCRBV20-or09_02												CSARGQNSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCGGGGGGCCCCAGGGGATACGCAGTATTTTGGCCCA	CASSRGAPGDTQYF	In	VDJ	2	56	0.0015003750937734434	0.0018759840541355398	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	6	0	8	18	-1	37	30	45	TCRBV05,TCRBV11													CASSRGAPGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTTCACAGGGGGGCAAACTATGGCTACACCTTCGGTTCG	CSAVHRGANYGYTF	In	VDJ	2	57	0.0015271675061622548	0.0019094837693879603	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	1	2	5	3	26	34	47	39	50		TCRBV20-01,TCRBV20-or09_02												CSAVHRGANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGTTCACTGTCGAGCAGTACTTCGGGCCG		Out	VDJ	2	57	0.0015271675061622548		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	4	6	0	8	26	-1	42	38	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCAGGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSQGRGKETQYF	In	VDJ	2	59	0.0015807523309398779	0.001976483199892801	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	3	1	2	26	42	49	43	51		TCRBV03-01,TCRBV03-02												CASSQGRGKETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACCATGACAGTCACAATGAGCAGTTCTTCGGGCCA	CSAHHDSHNEQFF	In	VDJ	2	59	0.0015807523309398779	0.001976483199892801	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	5	6	2	26	35	46	41	48		TCRBV20-01,TCRBV20-or09_02												CSAHHDSHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACAGGGGGTTGGAACACTGAAGCTTTCTTTGGACAA	CSATGTGGWNTEAFF	In	VDJ	2	60	0.0016075447433286892	0.0020099829151452213	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	1	1	2	3	26	36	49	38	52		TCRBV20-01,TCRBV20-or09_02												CSATGTGGWNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGRGACWYGGSMCTRTATYTCTGYGCCAGCAGCTCCCGAGGGAGGGTCGGGGCCAACACTGAAGCTTTCTTTGGACAA	CASSSRGRVGANTEAFF	In	VDJ	2	60	0.0016075447433286892	0.0020099829151452213	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	0	2	5	8	22	35	47	40	55	TCRBV12,TCRBV23													CASSSRGRVGANTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTCAGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLRVNTGELFF	In	VDJ	2	64	0.0017147143928839352	0.0021439817761549026	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	1	2	1	26	41	48	43	49		TCRBV12-03,TCRBV12-04												CASSLLRVNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCAATGCAGGGAGGGCAGATACGCAGTATTTTGGCCCA	CSASGNAGRADTQYF	In	VDJ	2	64	0.0017147143928839352	0.0021439817761549026	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	4	10	0	26	37	-1	47	54		TCRBV20-01,TCRBV20-or09_02												CSASGNAGRADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCTAGGGGAGGTGGCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSPLGEVALNTEAFF	In	VDJ	2	65	0.0017415068052727468	0.002177481491407323	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	1	0	6	6	26	39	51	45	57		TCRBV03-01,TCRBV03-02												CASSPLGEVALNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGCCGCAGGGCAGCACTGAAGCTTTCTTTGGACAA	CASSLPQGSTEAFF	In	VDJ	2	66	0.0017682992176615584	0.0022109812066597435	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	4	6	3	26	38	49	44	52		TCRBV12-03,TCRBV12-04												CASSLPQGSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCGCGTTTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	66	0.0017682992176615584		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	6	5	0	19	26	-1	42	38	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAACAGCCGAACACTGAAGCTTTCTTTGGACAA	CSASKQPNTEAFF	In	VDJ	2	71	0.0019022612796056157	0.002378479782921845	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	1	3	2	26	37	44	40	46		TCRBV20-01,TCRBV20-or09_02												CSASKQPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGATACAGATTACGAGCAGTACTTCGGGCCG	CSARGDTDYEQYF	In	VDJ	2	74	0.00198263851677205	0.0024789789286791064	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	6	1	4	0	8	26	-1	42	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGDTDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCCCAGGGAACAGGGAGTTCAGGGCTACACCTTCGGTTCG		Out	VDJ	2	74	0.00198263851677205		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	3	8	7	7	26	29	42	36	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGTTCCTCAGCCCCAGCATTTTGGTGAT	CASSEQVPQPQHF	In	VDJ	2	74	0.00198263851677205	0.0024789789286791064	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	4	6	0	4	23	-1	42	38	46		TCRBV06-01,TCRBV06-08												CASSEQVPQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTAAACGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLNGYNEQFF	In	VDJ	2	76	0.0020362233415496733	0.002545978359183947	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	4	5	0	26	38	-1	43	47		TCRBV12-03,TCRBV12-04				01,02								CASSLNGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACAGCACTCTATAATTCACCCCTCCACTTTGGGAAC	CASSRTALYNSPLHF	In	VDJ	3	83	0.0022237702282713536	0.0027804763659508894	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	5	3	0	4	26	-1	45	39	49		TCRBV03-01,TCRBV03-02												CASSRTALYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAATGTGGGCAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	83	0.0022237702282713536		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	8	0	1	6	1	26	40	50	46	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAACAGTTCTCCATGGGCCCCAGCATTTTGGTGAT	CSARGTVLHGPQHF	In	VDJ	3	86	0.002304147465437788	0.0028809755117081503	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	5	9	2	10	26	39	45	41	55		TCRBV20-01,TCRBV20-or09_02												CSARGTVLHGPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCACCCTGCTGGGAGGAAACACCATATATTTTGGAGAG	CASTLLGGNTIYF	In	VDJ	3	89	0.0023845247026042225	0.0029814746574654116	39	unresolved						TCRBJ01	TCRBJ01-03	01	7	0	8	4	7	0	20	30	-1	37	41	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLLGGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGACGAGCAGTACTTCGGGCCG	CASSQADEQYF	In	VDJ	3	90	0.002411317114993034	0.003014974372717832	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	5	5	0	0	26	-1	-1	42	45		TCRBV03-01,TCRBV03-02				01,02								CASSQADEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTTGGACAGGGTTTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	101	0.0027060336512699603		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	3	3	2	3	24	42	52	44	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGCAGGGGGCCAACTGAAGCTTTCTTTGGACAA	CASSESRGPTEAFF	In	VDJ	3	105	0.002813203300825206	0.003517470101504137	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	5	2	2	23	38	48	40	50		TCRBV06-01,TCRBV06-08												CASSESRGPTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTATCCCAGGGTCTACGAGCAGTACTTCGGGCCG	CASSHYPRVYEQYF	In	VDJ	4	141	0.00377773014682242	0.00472345985059127	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	3	6	1	26	40	51	46	52		TCRBV03-01,TCRBV03-02												CASSHYPRVYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGATGGGTCCCATTACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEDGSHYANTGELFF	In	VDJ	5	160	0.004286785982209838	0.005359954440387256	54	unresolved						TCRBJ02	TCRBJ02-02	01	1	0	9	0	2	10	23	39	44	41	54	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDGSHYANTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGGGATACGCAGTATTTTGGCCCA	CASSLGDTQYF	In	VDJ	6	195	0.00522452041581824	0.006532444474221969	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	6	2	6	1	0	26	39	-1	40	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCATCTCGGACAGGGCCACTCTGGAAACACCATATATTTTGGAGAG	XASSHLGQGHSGNTIYF	In	VDJ	7	208	0.0055728217768727896	0.006967940772503433	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	0	4	3	23	37	49	41	52	TCRBV04,TCRBV07,TCRBV17													XASSHLGQGHSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGGATGGGAGACCCAGTACTTCGGGCCA	CASSVEGWETQYF	In	VDJ	7	208	0.0055728217768727896	0.006967940772503433	39	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	5	11	0	5	3	4	24	36	44	39	48	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVEGWETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCGGGACAGGGACTACCTACGAGCAGTACTTCGGGCCG	CASSLVGTGTTYEQYF	In	VDJ	7	233	0.006242632086593077	0.007805433653813943	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	2	2	4	26	42	53	44	57		TCRBV12-03,TCRBV12-04												CASSLVGTGTTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTCCCCTCCGGGATACTGAAGCTTTCTTTGGACAA	CSARSPLRDTEAFF	In	VDJ	16	516	0.013824884792626729	0.017285853070248904	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	3	5	9	1	26	38	52	47	53		TCRBV20-01,TCRBV20-or09_02												CSARSPLRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGCAATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	66	2099	0.05623727360411532		37	TCRBV24						TCRBJ02	TCRBJ02-04	01	9	4	6	0	2	2	24	33	37	35	39		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-04	TCRBV24		TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCACTCTATAGGTCGTGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	9	2.411317114993034E-4		44	TCRBV22	TCRBV22-01	01				TCRBJ01	TCRBJ01-06	01	13	4	5	5	2	16	25	28	33	30	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV22-01+TCRBJ01-06	TCRBV22-01*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTTTGGGGGTGGGAGCTATGGCTACACCTTCGGTTCG	CASSFGGGSYGYTF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV22	TCRBV22-01	01				TCRBJ01	TCRBJ01-02	01	13	6	1	4	12	6	25	28	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGGSYGYTF+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCGGCGGGGGAGGCGAGCAGTACTTCGGGCCG	CASSLGGGGEQYF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	2	6	3	3	23	36	46	39	49													Vb 7.1	CASSLGGGGEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCGAGACTGAATAATGAGCAGTTCTTCGGGCCA	CASSPRLNNEQFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	7	3	4	23	36	43	39	47						01,02							Vb 7.1	CASSPRLNNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATACTTGGACTGAAGCTTTCTTTGGACAA	YASSQDTWTEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	10	5	1	3	22	39	43	40	46						01,02							Vb 7.1	YASSQDTWTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGACAAGAGACTAGCGCTATCCAAGAGACCCAGTACTTCGGGCCA	CASRQETSAIQETQYF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	2	6	1	0	4	23	-1	48	40	52						01,02							Vb 7.1	CASRQETSAIQETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGGATTACTGAAGCTTTCTTTGGACAA	CASSQDRITEAFF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	39	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	0	1	8	5	2	2	23	40	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDRITEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGACAAGTCATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTSHSNQPQHF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	6	0	0	5	23	-1	41	37	46													Vb 7.1	CASSQTSHSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCACCCGGGCCGATCCTACGAGCAGTACTTCGGGCCG	CASSHPGRSYEQYF	In	VDJ	5	144	0.0038581073839888545	0.004823958996348531	42	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	3	8	0	1	3	3	23	37	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSHPGRSYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTTATCCTACGAGCAGTACTTCGGGCCG	CASSLSYEQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	33	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	9	1	0	0	26	-1	-1	39	41						01,02							Vb 13.1	CASSLSYEQYF+TCRBV06-09+TCRBJ02-07	TCRBV06-09*01	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTACGGCGGGGGCATCTACGAGCAGTACTTCGGGCCG	CASSYGGGIYEQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	3	2	3	26	40	49	42	52													Vb 13.1	CASSYGGGIYEQYF+TCRBV06-09+TCRBJ02-07	TCRBV06-09*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGGATAGAAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASRIESSYNSPLHF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	45	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	5	8	0	2	4	26	37	42	39	46						01,02							Vb 13.1	CASRIESSYNSPLHF+TCRBV06-09+TCRBJ01-06	TCRBV06-09*01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTGGGACAGGGGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSWDRGRTGELFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	0	5	0	2	26	-1	51	39	53													Vb 13.1	CASSWDRGRTGELFF+TCRBV06-09+TCRBJ02-02	TCRBV06-09*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTGGGGGACAGGACCCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	16	4.286785982209838E-4		49	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	4	0	2	4	22	35	45	37	49														X+TCRBV12-01+TCRBJ01-03	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGAAGAGACCTTTCCAATCAGCCCCAGCATTTTGGTGAT	CATRRDLSNQPQHF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	4	10	3	1	3	18	35	38	36	41						01,02								CATRRDLSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATSGSSYNSPLHF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	5	1	8	0	0	2	18	-1	33	30	35				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGSSYNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAGAAGGGGTTAGGCAACTCCTACGAGCAGTACTTCGGGCCG	CATSKKGLGNSYEQYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	2	0	3	8	18	31	39	34	47														CATSKKGLGNSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGGGGCCTTTGAAGCTTTCTTTGGACAA	CATSRDRGAFEAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	5	1	7	1	5	18	35	42	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRGAFEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCGGACACCCGGAGGGTTGAAAAACTGTTTTTTGGCAGT	CATSRPDTRRVEKLFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	10	0	7	10	1	18	33	49	43	50														CATSRPDTRRVEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAACAGAGGCAAGGAGGGGAACAATCAGCCCCAGCATTTTGGTGAT	CATNRGKEGNNQPQHF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	10	0	3	4	3	18	34	44	38	47														CATNRGKEGNNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTAGCAGGGAATGGTTACACTGAAGCTTTCTTTGGACAA	CASSLAGNGYTEAFF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	3	4	7	18	30	39	34	46														CASSLAGNGYTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTAGATCTAGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CATSRVRSRGLNTEAFF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	1	0	8	1	18	34	48	42	49														CATSRVRSRGLNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGAAAAGAGGACAGGGGGCATCCTATAATTCACCCCTCCACTTTGGGAAC	CATRKRGQGASYNSPLHF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	0	1	7	1	18	29	47	36	48														CATRKRGQGASYNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCCGAAAAGGGGCCCCGGCACCGGGGAGCTGTTTTTTGGAGAA	CATSSPKRGPGTGELFF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	2	4	7	6	18	32	44	39	50														CATSSPKRGPGTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCCGGGGAGTCCAAGAGACCCAGTACTTCGGGCCA	CATSRARGVQETQYF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	3	1	2	3	18	34	41	36	44						01,02								CATSRARGVQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCGTAACTGACAGGGGGTTAAGAGAGACCCAGTACTTCGGGCCA	CATSTVTDRGLRETQYF	In	VDJ	1	45	0.001205658557496517	0.001507487186358916	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	1	4	8	5	18	31	48	39	53														CATSTVTDRGLRETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCCGACTACAGGGTTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CATRLQGSSNQPQHF	In	VDJ	1	47	0.00125924338227414	0.0015744866168637566	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	3	1	5	4	18	27	38	32	42														CATRLQGSSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCTTGGATCCGTGATTGGGGATGAAAAACTGTTTTTTGGCAGT	CATSRELGSVIGDEKLFF	In	VDJ	2	55	0.0014735826813846319	0.0018424843388831194	54	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	6	2	6	16	0	18	35	-1	51	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRELGSVIGDEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAGATGAGGTTCCGCCCCTCCACTTTGGGAAC	CATSRGDEVPPLHF	In	VDJ	2	57	0.0015271675061622548	0.0019094837693879603	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	1	13	5	5	18	34	43	39	48														CATSRGDEVPPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGTCCCGGCCATTGAAAAACTGTTTTTTGGCAGT	CATSREVPAIEKLFF	In	VDJ	2	62	0.0016611295681063123	0.002076982345650062	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	9	0	7	6	3	18	35	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREVPAIEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCAACTAATTCACCCCTCCACTTTGGGAAC	CATSRDSTNSPLHF	In	VDJ	2	62	0.0016611295681063123	0.002076982345650062	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	0	3	7	6	4	0	18	35	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDSTNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAACCAGGGTAGAGGCACTGAAGCTTTCTTTGGACAA	CATSRNQGRGTEAFF	In	VDJ	2	63	0.0016879219804951237	0.002110482060902482	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	4	3	6	18	33	41	36	47														CATSRNQGRGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGGACGGTCCCTACGAGCAGTACTTCGGGCCG	CATSRADGPYEQYF	In	VDJ	2	64	0.0017147143928839352	0.0021439817761549026	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	1	1	7	2	1	4	18	34	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRADGPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGACAGGGGGCTTGGAGAAAAACTGTTTTTTGGCAGT	CATSRDRGLGEKLFF	In	VDJ	2	68	0.0018218840424391813	0.0022779806371645843	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	0	8	0	5	18	-1	43	32	48														CATSRDRGLGEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGTCGTGGGTACTAACTCACCCCTCCACTTTGGGAAC	CATSRDVVGTNSPLHF	In	VDJ	2	79	0.0021166005787161078	0.002646477504941208	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	3	9	10	10	2	18	35	49	45	51						01,02								CATSRDVVGTNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCGCCCCGACAGGGGTTACACGAGCATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	80	0.002143392991104919		55	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	2	0	5	11	18	27	40	32	51														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGATAGCTAGGGTTGGGCAGCTGTTTTTTGGAGAA	CATSRDQIARVGQLFF	In	VDJ	4	129	0.0034562211981566822	0.004321463267562226	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	0	5	3	12	10	6	18	35	49	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDQIARVGQLFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGGGCAGCTCCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CATSRDQGSSATNEKLFF	In	VDJ	4	134	0.0035901832601007394	0.004488961843824328	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	0	1	8	18	35	41	36	49														CATSRDQGSSATNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGACAGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDRGSYNEQFF	In	VDJ	6	197	0.0052781052405958635	0.00659944390472681	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	1	0	0	18	-1	-1	30	39														CATSDRGSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTTCGCCGTCGGAAAAACTGTTTTTTGGCAGT	CASSFSPSEKLFF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-04	01	3	10	0	8	3	5	18	32	37	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSPSEKLFF+TCRBV07-02+TCRBJ01-04	TCRBV07-02*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCATAAAGGAATTTGGGGGAGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	9	2.411317114993034E-4		55	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	4	6	1	2	15	2	18	31	51	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTATCGGACTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSYRTSGGETQYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	2	4	3	0	18	31	-1	34	47														CASSYRTSGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCTACCGGATTTATAATTCACCCCTCCACTTTGGGAAC	CASSSYRIYNSPLHF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	4	1	8	4	6	2	18	31	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYRIYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACAGGGCTTTGAGCGGGGAGCTGTTTTTTGGAGAA	CASSNRALSGELFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	7	1	7	18	30	37	31	44														CASSNRALSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGACAGGGGACGGAGAGACCCAGTACTTCGGGCCA	CASSSTGDGETQYF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	4	1	4	18	31	40	32	44														CASSSTGDGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGACAGGGAGGGTATGGCTACACCTTCGGTTCG	CASSLVGQGGYGYTF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	5	2	4	18	34	44	36	48														CASSLVGQGGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGCGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLVATGNTEAFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	4	1	4	0	18	34	-1	38	44														CASSLVATGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCTACTGGGGTATCCACACTGAAGCTTTCTTTGGACAA	CASSLVYWGIHTEAFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	6	2	3	8	5	18	32	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVYWGIHTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGAGTTATGGGGGACAGGAAACAATGAGCAGTTCTTCGGGCCA	CASRELWGTGNNEQFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	4	5	10	2	18	29	47	39	49														CASRELWGTGNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCTTGGACAGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGAGTGELFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	0	4	3	3	18	30	44	33	47														CASSLGQGAGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGGGACTACCTACGAGCAGTACTTCGGGCCG	CASSPGTGTTYEQYF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	3	4	18	30	42	33	46														CASSPGTGTTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGCCCTAAGGACAGGGGGCCTAACTATGGCTACACCTTCGGTTCG	CASSGPKDRGPNYGYTF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	0	0	8	0	18	30	-1	38	49														CASSGPKDRGPNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGCATTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGIGANVLTF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	5	4	3	2	3	18	30	35	32	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGIGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCAGGGGTGGGTGAGACCCAGTACTTCGGGCCA	CASSLPGVGETQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	5	1	5	18	33	40	34	45														CASSLPGVGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGGGATTTACAATGAGCAGTTCTTCGGGCCA	CASSLVGIYNEQFF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	8	4	2	2	18	34	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGIYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTTCCGCACTCTGGAAACACCATATATTTTGGAGAG	CASSLFPHSGNTIYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	4	6	0	7	0	18	32	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFPHSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCACTATGCGGGACAGAACTATGGCTACACCTTCGGTTCG	CASSHYAGQNYGYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	2	8	0	18	30	-1	38	45														CASSHYAGQNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTTAGGGGGCCGGGACGGAAATGAAAAACTGTTTTTTGGCAGT	CASSPLGGRDGNEKLFF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	0	5	5	9	18	30	42	35	51														CASSPLGGRDGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGAGTGGTCCGACTCCTTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	3.7509377344336085E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	2	10	5	18	35	49	45	54						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGTTCCAAGTCTATAATTCACCCCTCCACTTTGGGAAC	CASSLFQVYNSPLHF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	3	4	6	3	4	3	18	32	38	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFQVYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATTACCAGGGTATCGGGACAGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSHYQGIGTGGPDTQYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	0	4	15	1	18	30	57	45	58														CASSHYQGIGTGGPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSLGTGSNTEAFF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	3	1	0	2	18	-1	42	34	44														CASSLGTGSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGAAACAGGGCCTGGAAACACCATATATTTTGGAGAG	CASSETGPGNTIYF	In	VDJ	1	15	4.018861858321723E-4	5.024957287863053E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	2	4	1	18	29	39	33	40														CASSETGPGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCTTTCCCGCCACGGGACAGGGGGTTCGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	4.286785982209838E-4		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	1	6	14	5	18	33	58	47	63														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASSPRTSGGYEQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	3	4	0	18	30	-1	34	47														CASSPRTSGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGATAGCGGGGGGGCCACCTACGAGCAGTACTTCGGGCCG	CASSDSGGATYEQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	0	2	2	3	18	30	43	32	46														CASSDSGGATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCGAGCGGAGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGSSGDSSYNEQFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	5	0	5	6	18	34	44	39	50						01,02								CASSLGSSGDSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGTGGCTAACTATGGCTACACCTTCGGTTCG	CASSLVVANYGYTF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	0	10	0	4	0	18	34	-1	38	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVVANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTAATAGCGGGGGTGGATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	4.554710106097953E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	3	4	5	18	32	45	36	50														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCAGGGCTGGGGACAGGGTGGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASRQGWGQGGSSYNSPLHF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	60	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	0	9	6	18	29	47	38	53														CASRQGWGQGGSSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGATGAACACTAAAGCTTTCTTTGGACAA	CASSPGQMNTKAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	9	2	10	18	30	39	32	49														CASSPGQMNTKAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGACAGGGCACTTACCTATGGCTACACCTTCGGTTCG	CASSLGDRALTYGYTF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	4	2	7	18	32	43	34	50														CASSLGDRALTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCAAGGGGGACCTAATGAAAAACTGTTTTTTGGCAGT	CASSHQGGPNEKLFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	3	5	2	18	30	41	35	43														CASSHQGGPNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCGGCGGGGCTTCTAACTATGGCTACACCTTCGGTTCG	CASSLVGGASNYGYTF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	7	3	0	5	3	18	32	43	37	46														CASSLVGGASNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACAGAGATAAGCACAGATACGCAGTATTTTGGCCCA	CASSPTEISTDTQYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	0	2	5	18	30	37	32	42														CASSPTEISTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTTAGCAGCTCGACACTGAAGCTTTCTTTGGACAA	CASSQV*QLDTEAFF	Stop	VDJ	1	24	6.430178973314757E-4		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	5	7	3	6	6	18	30	40	36	46						01,02								CASSQV*QLDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAAATAGCGGGGCCTACCAAGAGACCCAGTACTTCGGGCCA	CASSLGNSGAYQETQYF	In	VDJ	1	24	6.430178973314757E-4	8.039931660580885E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	5	3	0	4	3	18	34	46	38	49														CASSLGNSGAYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGATCTGACAGGGTTCCACGAGCAGTACTTCGGGCCG	CASSPDLTGFHEQYF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	5	8	4	18	30	45	38	49														CASSPDLTGFHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGAAGAAATAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	26	6.966027221090987E-4		56	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	5	18	30	49	46	54														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGACAATCTGGGACTAAAGCTTTCTTTGGACAA	CASSPRQSGTKAFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	9	9	12	0	18	30	-1	42	49						01,02								CASSPRQSGTKAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGCCCACAGGGCGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSLGPQGGLDTEAFF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	3	4	8	18	34	44	38	52														CASSLGPQGGLDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGACGCATAATGAAAAACTGTTTTTTGGCAGT	CASSLQTHNEKLFF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	4	2	5	18	30	36	32	41														CASSLQTHNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGCATTCAGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	34	9.109420212195906E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	7	7	0	18	32	-1	39	44														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCCAAGGGACAGGGTTACTGAAAAACTGTTTTTTGGCAGT	CASSYPRDRVTEKLFF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	7	6	4	18	31	46	37	50														CASSYPRDRVTEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATGAGCCGGGACGCGGATATGAAGCTTTCTTTGGACAA	CASSYEPGRGYEAFF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	0	7	7	7	7	18	31	43	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEPGRGYEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTTTGGCAGCTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	36	9.645268459972136E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	4	4	5	4	7	2	18	31	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCAGGATGGAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	37	9.91319258386025E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	4	4	1	2	6	18	33	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGGGGGTTTGGGAGAGACTGAAGCTTTCTTTGGACAA	CASRGGLGETEAFF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	5	0	10	18	-1	35	29	45														CASRGGLGETEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGCCTAGCTCAGGGGGTGGATATGGCTACACCTTCGGTTCG	CASSLVPSSGGGYGYTF	In	VDJ	1	38	0.0010181116707748366	0.0012729891795919734	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	5	9	4	18	34	50	43	54														CASSLVPSSGGGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGCTAGCGGGGGGGCGCGATACGCAGTATTTTGGCCCA	CASSLELAGGRDTQYF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	0	6	4	3	18	32	48	36	51														CASSLELAGGRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAAGGGAACAGGGTCGGAGGCTACACCTTCGGTTCG		Out	VDJ	2	51	0.0013664130318293858		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	8	7	5	18	34	47	41	52														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCCCCGACAGGCTCGCTATGGCTACACCTTCGGTTCG	CASSYPRQARYGYTF	In	VDJ	2	56	0.0015003750937734434	0.0018759840541355398	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	6	4	18	31	43	37	47														CASSYPRQARYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACTAACGGACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	56	0.0015003750937734434		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	1	9	0	0	5	18	-1	38	32	43						01,02								X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCCGGGACAGGGCGTGAAAAACTGTTTTTTGGCAGT	CASSSGTGREKLFF	In	VDJ	2	56	0.0015003750937734434	0.0018759840541355398	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	7	4	2	18	29	42	33	44														CASSSGTGREKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGGGAACCGCGAATGAAAAACTGTTTTTTGGCAGT	CASSLVGTANEKLFF	In	VDJ	2	79	0.0021166005787161078	0.002646477504941208	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	3	0	8	5	3	6	18	32	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGTANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACTTCGACAGGGACTTTATGAACACTGAAGCTTTCTTTGGACAA	CASSLDFDRDFMNTEAFF	In	VDJ	3	82	0.002196977815882542	0.002746976650698469	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	0	4	6	18	35	46	39	52														CASSLDFDRDFMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGGTTCTAGGCCAACCTACGAGCAGTACTTCGGGCCG	CASSLDGSRPTYEQYF	In	VDJ	3	82	0.002196977815882542	0.002746976650698469	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	1	7	2	0	13	18	-1	36	32	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGSRPTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTATCAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSFYQGSYEQYF	In	VDJ	3	102	0.0027328260636587717	0.0034169709557468762	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	0	4	0	18	32	-1	36	41														CASSFYQGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGAGGGGGGCGGTTGAAAAACTGTTTTTTGGCAGT	CASSLERGAVEKLFF	In	VDJ	3	109	0.0029203729503804524	0.003651468962513819	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	0	5	1	7	1	5	18	35	42	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLERGAVEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTTCGCAGGGGGCGAATGGCTACACCTTCGGTTCG	CASSLGSQGANGYTF	In	VDJ	4	142	0.0038045225592112314	0.00475695956584369	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	0	6	5	2	18	34	47	39	49														CASSLGSQGANGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAACAGTATCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGTVSVNTEAFF	In	VDJ	15	466	0.012485264173186154	0.015610867307627885	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	5	0	2	6	18	34	40	36	46														CASSLGTVSVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCCCGGGACAGAGTCAGATACGCAGTATTTTGGCCCA	CASSFPGTESDTQYF	In	VDJ	24	769	0.020603365126996034	0.025761281029111252	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	4	4	3	18	32	43	36	46														CASSFPGTESDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGTTGCGGGGGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASVAGAPYNEQFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	7	2	2	7	3	26	31	45	38	48														CASVAGAPYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCGTGCGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASGRAGSNQPQHF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	4	0	3	0	26	38	-1	41	46						01,02								CASGRAGSNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCCGGGACAGGCTCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASGPGTGSNTGELFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	2	4	4	26	37	49	41	53														CASGPGTGSNTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAGGGCTACAATCAGCCCCAGCATTTTGGTGAT	CASGLGQGYNQPQHF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	3	0	3	26	-1	49	42	52														CASGLGQGYNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCACCCGCGGACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CATRGQLNEKLFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	1	5	4	7	2	26	31	44	38	46														CATRGQLNEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGACCTGACAGGGGGAGGCTACACCTTCGGTTCG	CASGLDLTGGGYTF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	1	8	4	1	26	42	55	46	56														CASGLDLTGGGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCAAATTGGGAACAAAAGGGCGGCTACACCTTCGGTTCG	CANWEQKGGYTF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	12	0	8	8	5	10	26	31	40	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANWEQKGGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCTCTTGTAGACAGGGGGCGCGGGAAGCTTTCTTTGGACAA		Out	VDJ	2	70	0.0018754688672168042		46	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	8	8	4	26	38	56	46	60														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCCGGGACAGTAAACTCCTGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	123	0.003295466723823813		53	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	3	10	26	39	49	42	59														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTAGCAGTCTGACCTACGAGCAGTACTTCGGGCCG	CASSSLTYEQYF	In	VDJ	24	772	0.02068374236416247	0.025861780174868513	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	8	4	5	2	2	5	26	35	40	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLTYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTAAACAGGGGATAAGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	4.554710106097953E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	2	6	3	6	20	37	47	40	53														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACTGGGGACAGGGGGCGGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQLGTGGGYSNQPQHF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	57	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	0	0	3	5	20	35	50	38	55														CASSQLGTGGGYSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTAACAGGGGAGGAATCAGCCCCAGCATTTTGGTGAT	CASS*QGRNQPQHF	Stop	VDJ	1	21	5.626406601650412E-4		42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	4	2	3	20	32	41	34	44														CASS*QGRNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTATGGGGGTGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	5.894330725538528E-4		50	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	0	6	1	1	3	5	20	37	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCGCATGGGGGGGCTGAAGCTTTCTTTGGACAA	CASSPHGGAEAFF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	6	7	0	20	31	-1	38	45														CASSPHGGAEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTCACTCAGTGTTCTGCCTACGAGCAGTACTTCGGGCCG	CASSLTQCSAYEQYF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	6	4	5	2	7	7	20	31	41	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTQCSAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCAACCCTCAAGGACGTCACAAAGTCGGGCCAACCGGGGCC	CASSNPQGRHKVGPT	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-06	01	6	1	7	24	10	19	20	31	45	41	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNPQGRHKVGPT+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01		TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTACTCTGTACTGTGAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	70	0.0018754688672168042		50	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	3	10	7	1	11	20	37	41	38	52						01,02								X+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCCCCTCGCGGGGGGCTCGGCACTGAAGCTTTCTTTGGACAA	CASRSPRGGLGTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	1	4	8	5	23	34	50	42	55														CASRSPRGGLGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCGACAGCTACCTAACACTGAAGCTTTCTTTGGACAA	CASSTRQLPNTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	2	4	6	23	35	44	39	50														CASSTRQLPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGACAGAGAGCTACGAGCAGTACTTCGGGCCG	CASSRTESYEQYF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	3	1	4	23	35	42	36	46														CASSRTESYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTCCGGGTTATGGCTACACCTTCGGTTCG	CASSAPGYGYTF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	5	4	1	23	35	43	39	44						01,02								CASSAPGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGCGGCCGGGGCTTTCTTTGGACAA	CASSYLAAGAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	11	2	5	23	39	45	41	50						01,02								CASSYLAAGAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTCTGGCGGGGCGTACTATGACTACACCTTCGGTTCG	CASSPSGGAYYDYTF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	3	10	7	10	23	35	48	42	58														CASSPSGGAYYDYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTTTTCGGGACGGGGAGCTGTTTTTTGGAGAA	CASSAFRDGELFF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	3	7	6	0	23	35	-1	41	46														CASSAFRDGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCAGTCAGTCTACACCTTCGGTTCG	CASSYSQSVYTF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	10	1	5	23	40	44	41	49														CASSYSQSVYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCCGACTAGTTATCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	2.679241238881149E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	2	8	6	6	4	23	30	42	36	46						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGGGGAAAGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	2.947165362769264E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	5	1	3	0	6	23	-1	39	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTTGACACACCGGGACAGTACTACGAGCAGTACTTCGGGCCG	CASSYSFDTPGQYYEQYF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	3	12	2	23	40	59	52	61														CASSYSFDTPGQYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAAGCCGTCGGACGGCCCAATCAGCCCCAGCATTTTGGTGAT	CASEAVGRPNQPQHF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	8	1	7	3	9	4	23	32	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASEAVGRPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCCCCCGGGAACACTGAAGCTTTCTTTGGACAA	CAISSPGNTEAFF	In	VDJ	1	11	2.947165362769264E-4	3.684968677766239E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	1	6	0	23	34	-1	40	43						01,02								CAISSPGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATCCGGGAACACTGAAGCTTTCTTTGGACAA	CASSLSGNTEAFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	5	1	4	0	23	36	-1	40	43						01,02								CASSLSGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGACAGGAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAIGTGDSNQPQHF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	4	0	2	3	23	30	40	32	43														CAIGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCATGGCCCTAACAGGGAGTCACGAGCAGTACTTCGGGCCG	CAIMALTGSHEQYF	In	VDJ	1	13	3.4830136105454935E-4	4.354962982814646E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	3	5	11	4	23	30	47	41	51														CAIMALTGSHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAGAACAGGGGGGTTTATGGCTACACCTTCGGTTCG	CASSYSKNRGVYGYTF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	1	5	5	3	23	40	53	45	56														CASSYSKNRGVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTAATACATCCCTATAATTCACCCCTCCACTTTGGGAAC	CASSYSVIHPYNSPLHF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	6	2	6	2	23	40	49	46	51														CASSYSVIHPYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGGGGTCTTATAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSRGSYSSYEQYF	In	VDJ	1	14	3.7509377344336085E-4	4.6899601353388496E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	2	0	2	8	23	36	44	38	52														CASSSRGSYSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGAGGGATGGAAATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	4.018861858321723E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	6	1	6	23	38	44	39	50														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAGAAGGGCATGTTAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	16	4.286785982209838E-4		52	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	7	5	3	0	5	8	23	33	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACTGACCAGGGATACGGTTCACCCCTCCACTTTGGGAAC	CASSTDQGYGSPLHF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	3	9	7	6	23	34	46	41	52														CASSTDQGYGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGTATCTCTGGAAACACCATATATTTTGGAGAG	CASSRISGNTIYF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	5	9	0	3	1	23	34	39	37	40						01,02								CASSRISGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCTACAGGGGGTACTGGAAACACCATATATTTTGGAGAG	CASRPTGGTGNTIYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	1	2	4	2	23	34	46	38	48														CASRPTGGTGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGACACTGAAGCTTTCTTTGGACAA	CASSYSGDTEAFF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	6	1	3	0	0	23	-1	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTACAGGGGGCGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYFTGGAGANVLTF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	3	0	4	2	3	23	39	50	41	53														CASSYFTGGAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACCCAGTAGAAGAGACCCAGTACTTCGGGCCA	CASRDPVEETQYF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	2	7	3	1	7	23	34	38	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDPVEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCAGGGGGCGATTCTACGAGCAGTACTTCGGGCCG	CASSPRGRFYEQYF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	3	2	4	23	35	45	37	49														CASSPRGRFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGGGATTTACGAGCTTTCTTTGGACAA	CASSYSGDLRAFF	In	VDJ	1	18	4.822634229986068E-4	6.029948745435664E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	8	10	2	6	23	40	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGDLRAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAGTAGGGGGGGGCTACCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	19	5.090558353874183E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	9	9	0	2	4	4	23	31	42	35	46														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTGGGACAGGGCCTACGAGCAGTACTTCGGGCCG	CASSEWDRAYEQYF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	4	0	23	35	-1	39	48														CASSEWDRAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGGACTGACTGAAGCTTTCTTTGGACAA	CASSYLGLTEAFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	0	10	5	1	1	23	39	46	40	47						01,02								CASSYLGLTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCGGGACAGATTAATTCACCCCTCCACTTTGGGAAC	CASSYSPGQINSPLHF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	6	3	2	23	40	50	43	52														CASSYSPGQINSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCCCTTCGCCTCCTTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYSPFASLSSYNEQFF	In	VDJ	1	20	5.358482477762298E-4	6.69994305048407E-4	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	5	5	0	16	0	23	40	-1	56	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPFASLSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCGGGGACAGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSAGTGNYNEQFF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	3	4	2	23	34	47	38	49														CASSAGTGNYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGCCTTTTCCTACGAGCAGTACTTCGGGCCG	CASSYSAFSYEQYF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	7	1	0	4	23	-1	43	40	47						01,02								CASSYSAFSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTCGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSYSVVAKNIQYF	In	VDJ	1	21	5.626406601650412E-4	7.034940203008275E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	0	0	10	0	0	4	23	-1	42	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSVVAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTGGGCCGACCGCCTCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	21	5.626406601650412E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	8	0	0	2	9	23	29	35	31	44														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATACGGGTAACCCCCAATGAGCAGTTCTTCGGGCCA	CASSIRVTPNEQFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	6	3	7	23	35	42	38	49						01,02								CASSIRVTPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACCCGAAGGAGGGTCTTGGAATTCACCCCTCCACTTTGGGAAC	CASSRPEGGSWNSPLHF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	10	0	7	9	6	23	35	50	44	56														CASSRPEGGSWNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGGGCAGTCTCTGGAAACACCATATATTTTGGAGAG	CASSDRAVSGNTIYF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	5	8	0	0	4	3	23	35	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDRAVSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTAGGGTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	5.894330725538528E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	5	3	2	1	1	23	39	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGAGGGTAAGGTAGGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	22	5.894330725538528E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	11	0	8	2	9	23	40	47	42	56														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTCGGGGGGCGATCTCTGAAGCTTTCTTTGGACAA	CASIRGAISEAFF	In	VDJ	1	22	5.894330725538528E-4	7.369937355532478E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	1	6	2	6	23	33	42	35	48														CASIRGAISEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGAACAGTGGCACTGAAGCTTTCTTTGGACAA	CASSVNSGTEAFF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	4	4	3	23	35	43	39	46														CASSVNSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGGGACAGTCCTACGAGCAGTACTTCGGGCCG	CAISPGQSYEQYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	1	2	0	23	35	-1	37	44														CAISPGQSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAACAGGGGGAAAGTGAAAAACTGTTTTTTGGCAGT	CASSQQGESEKLFF	In	VDJ	1	25	6.698103097202872E-4	8.374928813105088E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	1	7	2	4	23	35	45	37	49														CASSQQGESEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGATCCGGGCGGGACTCTGGAAACACCATATATTTTGGAGAG	CANRSGRDSGNTIYF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	7	3	0	6	0	23	34	-1	40	46														CANRSGRDSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGGGGCCTTCACTTAGATACGCAGTATTTTGGCCCA	CASTGGLHLDTQYF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	1	5	0	9	23	-1	40	33	49														CASTGGLHLDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAGATACAGGGGGTTTCAACGAGCAGTACTTCGGGCCG	CASSEDTGGFNEQYF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	5	7	5	23	34	49	41	54														CASSEDTGGFNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGTCCAAGTCTCCTAGTCGACAATGAAAAACTGTTTTTTGGCAGT	CASSDCPSLLVDNEKLFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	8	5	11	5	23	39	54	50	59						01,02								CASSDCPSLLVDNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGGACAGGGTAACAATGAGCAGTTCTTCGGGCCA	CASSYLGQGNNEQFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	5	2	2	23	38	49	40	51														CASSYLGQGNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGTTCGTAACACTGAAGCTTTCTTTGGACAA	CASSYGVRNTEAFF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	6	2	2	0	5	23	-1	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAGAGAACCAGGACGGAACACTGAAGCTTTCTTTGGACAA	CATREPGRNTEAFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	1	7	1	7	1	23	34	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATREPGRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGACAGAGATAACACTGAAGCTTTCTTTGGACAA	CATDRDNTEAFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	2	5	2	2	4	23	30	37	32	41														CATDRDNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACAGGGGTCCTATAATTCACCCCTCCACTTTGGGAAC	CASRGQGSYNSPLHF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	2	1	0	0	23	-1	-1	34	44														CASRGQGSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATCAACCGGGACAGGGGATTCGGCTACACCTTCGGTTCG	CASSINRDRGFGYTF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	8	7	4	23	35	52	42	56														CASSINRDRGFGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACGGGGTTCGGGGAGCTGTTTTTTGGAGAA	CASSSGTGFGELFF	In	VDJ	1	32	8.573571964419676E-4	0.0010719908880774513	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	4	0	7	7	2	6	23	36	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTGFGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTGGGACGGCAACTATGGCTACACCTTCGGTTCG	CASSPWDGNYGYTF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	7	2	4	3	23	35	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWDGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCATAGGTCGGGAGATGGCTACACCTTCGGTTCG	CASSYHRSGDGYTF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	2	6	7	0	23	38	-1	45	51														CASSYHRSGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCAGGTCACGGGATTAACACCATATATTTTGGAGAG		Out	VDJ	1	34	9.109420212195906E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	8	3	7	10	2	23	34	49	44	51														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACTAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSPLGGSGNTIYF	In	VDJ	1	35	9.377344336084021E-4	0.0011724900338347124	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	5	1	0	5	0	23	35	-1	40	46														CASSPLGGSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAAACATTAACTATGGCTACACCTTCGGTTCG	CASSRNINYGYTF	In	VDJ	1	37	9.91319258386025E-4	0.0012394894643395532	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	6	1	4	1	23	35	42	39	43														CASSRNINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGGGCTGAGAGGAAACACCATATATTTTGGAGAG	CASSDRGLRGNTIYF	In	VDJ	1	39	0.001044904083163648	0.0013064888948443939	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	0	4	0	5	23	-1	45	35	50														CASSDRGLRGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSDGATGELFF	In	VDJ	1	39	0.001044904083163648	0.0013064888948443939	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	7	0	4	3	0	23	35	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGATGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGAACAGGGATACGAGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	40	0.0010716964955524595		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	4	4	6	23	35	45	39	51														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGACAGGGGCACAATGAGCAGTTCTTCGGGCCA	CASSDGQGHNEQFF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	5	3	1	23	35	47	38	48														CASSDGQGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTAACTTGGGACTAGCGGGGGGGCTTGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	48	0.0012860357946629514		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	5	7	4	23	34	57	41	61														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCCGAGGACTGGATAGATACGCAGTATTTTGGCCCA	CAISAEDWIDTQYF	In	VDJ	2	50	0.0013396206194405745	0.0016749857626210177	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	5	5	4	23	35	45	40	49						01,02								CAISAEDWIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGCACTTCCTAAATTCACCCCTCCACTTTGGGAAC	CASMHFLNSPLHF	In	VDJ	2	71	0.0019022612796056157	0.002378479782921845	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	3	10	7	3	5	23	33	39	36	44						01,02								CASMHFLNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGACAGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASGTGDSNQPQHF	In	VDJ	2	78	0.002089808166327296	0.0026129777896887877	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	2	0	0	1	23	-1	42	32	43														CASGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCTCGGGGTTGGGCTTGCCGATACGCAGTATTTTGGCCCA	CASSYSLGVGLADTQYF	In	VDJ	2	79	0.0021166005787161078	0.002646477504941208	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	6	3	11	23	40	48	43	59														CASSYSLGVGLADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGGAAGGGAGGGACCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	3	86	0.002304147465437788		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	9	0	2	6	1	23	33	46	39	47														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGAGGAGGCGCCCGCTCCCACAGATACGCAGTATTTTGGCCCA	CASKEEAPAPTDTQYF	In	VDJ	4	114	0.0030543350123245095	0.0038189675387759205	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	1	2	1	13	23	33	39	34	52														CASKEEAPAPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCAGCGGGCATGAACTGTTTTTTGGCAGT	CASRTSGHELFF	In	VDJ	4	133	0.003563390847711928	0.004455462128571907	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	6	4	12	4	4	23	34	44	38	48						01,02								CASRTSGHELFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCACCCCAACAGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASTPTPTGLNTEAFF	In	VDJ	4	136	0.0036437680848783625	0.004555961274329169	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	0	11	1	23	33	50	44	51														CASTPTPTGLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGCCGTGGGGATTCTTGAAGCTTTCTTTGGACAA	CASSPAVGILEAFF	In	VDJ	4	136	0.0036437680848783625	0.004555961274329169	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	0	8	7	9	4	23	35	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAVGILEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACTTGCCCGACAGTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	7	222	0.00594791555031615		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	5	2	8	3	23	30	43	38	46														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAGGGACTGGCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAIGTGDSNQPQHF	In	VDJ	17	534	0.014307148215625336	0.01788884794479247	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	10	0	10	0	2	5	23	30	38	32	43						01,02								CAIGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGGGGTCTTAGGCGATGAAAAACTGTTTTTTGGCAGT	CASIGVLGDEKLFF	In	VDJ	19	604	0.01618261708284214	0.020233828012461895	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	5	2	6	1	9	23	33	39	34	48														CASIGVLGDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGGTGGCAGATCAAAAACTGTTTTTTGGCAGT	CASSPSVADQKLFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	2	4	5	9	7	3	24	39	49	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSVADQKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCCGGGACAGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPPGQLNTEAFF	In	VDJ	1	9	2.411317114993034E-4	3.014974372717832E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	0	3	1	24	38	48	41	49													Vb 18	CASSPPGQLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGTAAAGCGGCATTTACAAAGTCGAGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	10	2.679241238881149E-4		55	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	6	5	7	5	15	24	36	46	41	61						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01	TCRBJ02-06*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGTAGGCCGCTCTGGAAACACCATATATTTTGGAGAG	CASSVGRSGNTIYF	In	VDJ	1	10	2.679241238881149E-4	3.349971525242035E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	6	5	4	0	3	3	24	35	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSVGRSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCGCGGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSRAADTGELFF	In	VDJ	1	12	3.2150894866573784E-4	4.0199658302904426E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	5	3	2	3	24	37	43	39	46						01,02							Vb 18	CASSRAADTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAAGGACAGGGATTCAATGAGCAGTTCTTCGGGCCA	CASSEGQGFNEQFF	In	VDJ	1	16	4.286785982209838E-4	5.359954440387256E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	6	3	3	24	36	47	39	50													Vb 18	CASSEGQGFNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGTATCCAAGAGACCCAGTACTTCGGGCCA	CASSQGIQETQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	4	5	3	1	0	3	24	-1	41	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQGIQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGACCCAGGGGCCGAGCAGTACTTCGGGCCG	CASSPDPGAEQYF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	6	5	1	24	38	49	43	50													Vb 18	CASSPDPGAEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTACGAGACCTATGGCTACACCTTCGGTTCG	CASSYETYGYTF	In	VDJ	1	17	4.554710106097953E-4	5.694951592911461E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	6	0	24	35	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSYETYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTGGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPWTGDTGELFF	In	VDJ	1	19	5.090558353874183E-4	6.364945897959867E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	2	3	2	0	24	38	-1	40	49													Vb 18	CASSPWTGDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTAGCGGGGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	5.626406601650412E-4		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	2	1	2	24	38	51	39	53													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGGTTAACTCTGGAAACACCATATATTTTGGAGAG	CASSPTVNSGNTIYF	In	VDJ	1	23	6.162254849426642E-4	7.704934508056681E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	2	7	0	0	6	24	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTVNSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTACGGGACTAGCGGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASYGTSGGPYNEQFF	In	VDJ	1	26	6.966027221090987E-4	8.709925965629292E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	0	1	2	2	1	24	34	51	36	52													Vb 18	CASYGTSGGPYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTAGATCCTAACTATGGCTACACCTTCGGTTCG	CASSPLDPNYGYTF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	5	8	0	0	3	24	-1	43	40	46						01,02							Vb 18	CASSPLDPNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTACGGGGGGCAGCCCCCGAAGCTTTCTTTGGACAA	CASSPVRGAAPEAFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	8	3	8	24	39	49	42	57													Vb 18	CASSPVRGAAPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCCCCTTTTCCCGGGACGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPSPFPGTENTEAFF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	54	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	7	1	13	3	24	38	56	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSPFPGTENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACGCCGACGAACTATGGCTACACCTTCGGTTCG	CASSPTPTNYGYTF	In	VDJ	1	27	7.233951344979101E-4	9.044923118153496E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	2	7	2	6	1	24	38	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTPTNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGACAGGGGCTGGCAACACCATATATTTTGGAGAG	CASSPGTGAGNTIYF	In	VDJ	1	28	7.501875468867217E-4	9.379920270677699E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	2	7	1	5	24	38	49	39	54													Vb 18	CASSPGTGAGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPGVNTEAFF	In	VDJ	1	29	7.769799592755332E-4	9.714917423201902E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	2	0	0	0	24	-1	-1	39	43													Vb 18	CASSPGVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGATTCGGCTACGACTGGCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	8.037723716643446E-4		50	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	2	10	3	12	3	24	38	54	50	57						01,02							Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACGGACAGGGGTTTGGAAACACCATATATTTTGGAGAG	CASSDGQGFGNTIYF	In	VDJ	1	30	8.037723716643446E-4	0.0010049914575726107	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	2	3	3	2	24	36	48	39	50													Vb 18	CASSDGQGFGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTTACCACCGGTGGCAGACTATGGCTACACCTTCGGTTCG	CASLPPVADYGYTF	In	VDJ	1	31	8.305647840531562E-4	0.001038491172825031	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	3	5	0	24	41	-1	46	49													Vb 18	CASLPPVADYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCACTTGGGAGTGCTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	8.573571964419676E-4		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	2	0	6	4	24	38	49	44	53													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAACAGGGTAATACGCAGTATTTTGGCCCA	CASSQQGNTQYF	In	VDJ	1	33	8.841496088307792E-4	0.0011054906033298717	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	7	1	2	24	37	44	38	46													Vb 18	CASSQQGNTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGACATCGACAAGAGACCCAGTACTTCGGGCCA	CASSPGHRQETQYF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	6	2	1	4	24	38	44	39	48													Vb 18	CASSPGHRQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGACTACTACAATGAGCAGTTCTTCGGGCCA	CASSRDYYNEQFF	In	VDJ	1	34	9.109420212195906E-4	0.0011389903185822922	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	3	0	0	24	-1	-1	37	44						01,02							Vb 18	CASSRDYYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAACCCCACGTGGCAGGTGAAACTGAAGCTTTCTTTGGACAA	CASSQPHVAGETEAFF	In	VDJ	1	36	9.645268459972136E-4	0.0012059897490871328	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	5	8	4	24	41	53	49	57													Vb 18	CASSQPHVAGETEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAATACCTACGAGCAGTACTTCGGGCCG	CASSPNTYEQYF	In	VDJ	1	39	0.001044904083163648	0.0013064888948443939	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	2	8	2	0	3	24	-1	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPNTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGACAGCTACGAGCAGTACTTCGGGCCG	CASSQDSYEQYF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	3	1	0	24	37	-1	38	44													Vb 18	CASSQDSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGSYNEQFF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	0	8	1	0	0	24	-1	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAAACCTACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLNLQNTGELFF	In	VDJ	1	40	0.0010716964955524595	0.001339988610096814	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	4	3	6	1	7	0	24	37	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLNLQNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGATACTGGAAACACCATATATTTTGGAGAG	CASSPTDTGNTIYF	In	VDJ	1	42	0.0011252813203300824	0.001406988040601655	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	5	2	0	3	24	-1	43	39	46													Vb 18	CASSPTDTGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGACCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	42	0.0011252813203300824		40	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	1	2	7	3	0	2	24	-1	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCCTTAAACACAGATACGCAGTATTTTGGCCCA	CASSPALNTDTQYF	In	VDJ	1	43	0.001152073732718894	0.0014404877558540751	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	2	10	0	2	0	6	24	-1	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPALNTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPTATNEKLFF	In	VDJ	1	45	0.001205658557496517	0.001507487186358916	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	5	0	0	0	24	-1	-1	39	43													Vb 18	CASSPTATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSPGTGGYEQYF	In	VDJ	1	46	0.0012324509698853285	0.0015409869016113362	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	3	1	0	24	38	-1	39	50													Vb 18	CASSPGTGGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACGGTTGGGGGACTGAAGCTTTCTTTGGACAA	CASSPDGWGTEAFF	In	VDJ	1	47	0.00125924338227414	0.0015744866168637566	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	6	1	5	8	0	24	38	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDGWGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGACAGGGTCTTCGAGCAGTACTTCGGGCCG	CASSPGDRVFEQYF	In	VDJ	2	48	0.0012860357946629514	0.001607986332116177	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	6	1	4	24	39	49	40	53													Vb 18	CASSPGDRVFEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACAGCTTCTGGAAACACCATATATTTTGGAGAG	CASSPGTASGNTIYF	In	VDJ	2	50	0.0013396206194405745	0.0016749857626210177	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	5	1	0	2	24	-1	46	39	48													Vb 18	CASSPGTASGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGGTTATCGGGTCGATGAGCAGTTCTTCGGGCCA	CASSQGYRVDEQFF	In	VDJ	2	52	0.0013932054442181974	0.0017419851931258583	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	8	8	3	24	37	49	45	52						01,02							Vb 18	CASSQGYRVDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPPSVNTEAFF	In	VDJ	2	56	0.0015003750937734434	0.0018759840541355398	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	5	0	2	0	24	41	-1	43	46						01,02							Vb 18	CASSPPSVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGACGACGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPPTTVNTEAFF	In	VDJ	2	60	0.0016075447433286892	0.0020099829151452213	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	2	7	0	0	5	24	-1	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPTTVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCCGGACAGGACACAGATACGCAGTATTTTGGCCCA	CASSSGQDTDTQYF	In	VDJ	2	63	0.0016879219804951237	0.002110482060902482	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	4	2	4	1	24	35	46	39	47													Vb 18	CASSSGQDTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCCTTCCGGGACAGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPPLPGQRNTEAFF	In	VDJ	2	67	0.0017950916300503697	0.002244480921912164	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	1	9	2	24	38	54	47	56													Vb 18	CASSPPLPGQRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTATACCCCCCCAGGGGGTATCCGGGGAGCTGTTTTTTGGAGAA	CASSLIPPQGVSGELFF	In	VDJ	2	67	0.0017950916300503697	0.002244480921912164	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	1	6	11	3	24	37	55	48	58													Vb 18	CASSLIPPQGVSGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCTGGGGCAGGCGAAGAAAAACTGTTTTTTGGCAGT	CASSAGAGEEKLFF	In	VDJ	2	70	0.0018754688672168042	0.0023449800676694247	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	7	0	8	4	7	24	35	44	39	51													Vb 18	CASSAGAGEEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAATTTGGTCGCAGGGACCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	75	0.0020094309291608615		47	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	7	7	12	0	24	39	-1	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACCTCAGACAGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASTSDREYNEQFF	In	VDJ	3	98	0.002625656414103526	0.0032829720947371945	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	3	4	6	2	24	33	46	39	48													Vb 18	CASTSDREYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGACACCCGGGGTGAGCAGTTCTTCGGGCCA	CASSPLDTRGEQFF	In	VDJ	4	119	0.003188297074268567	0.003986466115038022	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	1	1	6	9	1	7	24	40	46	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLDTRGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1573B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1420	1135	271	13	0	924	748	164	12	0	37324	29851	7128	345	0	0.105221361	8.54235744	0.11218328	8.7465477				67687	0.0165182408	0.0709188953	0.0567195378	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:02	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1245,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 553,type of chemo:carbo/taxol	0.7992957528619448	MSKCC- Snyder- P01-02		1118.0	
